cephalosporin c has been researched along with beta-lactams in 471 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 105 (22.29) | 18.7374 |
| 1990's | 23 (4.88) | 18.2507 |
| 2000's | 138 (29.30) | 29.6817 |
| 2010's | 152 (32.27) | 24.3611 |
| 2020's | 53 (11.25) | 2.80 |
| Authors | Studies |
|---|---|
| Dornbusch, K; Nord, CE; Olsson, B | 1 |
| Dewdney, JM; Munro, AC; Smith, H; Wheeler, AW | 1 |
| Kovalenko, LP; Solov'ev, VN | 1 |
| Michel-Briand, Y | 1 |
| Baker, CN; Miller, JM; Thornsberry, C | 1 |
| Sykes, RB | 1 |
| Abraham, EP | 1 |
| Rolinson, GN | 1 |
| Boyd, DB | 2 |
| Fu, KP; Neu, HC | 2 |
| Adriaens, P; Anné, J; Dumon, L; Eyssen, H | 1 |
| Vandamme, EJ | 1 |
| Gunda, ET | 1 |
| Richmond, MH | 2 |
| Alford, RH; Harris, LF; Jackson, RT | 1 |
| Haga, N; Itani, H; Kikkawa, I; Nagata, W; Narisada, M; Ohtani, M; Okada, T; Onoue, H; Satoh, H; Tsuji, T; Yoshida, T | 1 |
| Chakrabarti, P; Raychowdhury, M | 1 |
| Andrews, JM; Bedford, KA; Wise, R | 1 |
| Beckman, W; Lessie, TG | 1 |
| Fukuoka, Y; Minami, H; Momonoi, K; Ohashi, T; Saikawa, I; Sakai, H; Takashita, Y; Yamamoto, Y | 1 |
| Abraham, EP; Huddleston, JA | 1 |
| Mitsuhashi, S; Une, T | 1 |
| Hashimoto, M; Kamiya, T | 1 |
| Gaines, K; Lang, JE; Lukes, AL; Pikal, MJ | 1 |
| Hammes, WP; Seidel, H | 1 |
| Gunda, TE; Jászberényi, JC | 1 |
| Arcamone-Cainelli, G; Bernardi, L; Foglio, M; Franceschi, G; Masi, P; Palamidessi, G; Suarato, A | 1 |
| Belevich, EM; Veĭnberg, GA | 1 |
| Rao, VS; Virudachalam, R | 1 |
| Neu, HC | 2 |
| Lang, JE; Lukes, AL; Pikal, MJ | 1 |
| Koppel, GA; Mahoney, DF; Turner, JR | 1 |
| Boyd, DB; Hermann, RB; Marsh, MM; Presti, DE | 1 |
| Cimarusti, CM; Dolfini, JE; Kocy, O; Wojtkowski, PW | 1 |
| Kishi, Y; Nakatsuka, SI; Tanino, H | 1 |
| Stapley, EO; Zimmerman, SB | 1 |
| Sugiyama, I; Watanabe, N | 1 |
| Brochu, A; Brochu, N; Dolence, EK; Lavoie, MC; Malouin, F; McKee, JA; Miller, MJ; Minnick, AA; Nicas, TI; Parr, TR | 1 |
| Dolence, EK; Lin, CE; Miller, MJ; Minnick, AA; Payne, SM | 1 |
| Christensen, BG; Kondo, S; Kudo, T; Murai, Y; Okonogi, T; Shibahara, S; Yoshida, T | 1 |
| Lucain, C; Marchou, B; Michea-Hamzehpour, M; Pechère, JC | 1 |
| Hamashima, Y; Ishikura, K; Konoike, T; Kubota, T; Minami, K; Motokawa, K; Nakashimizu, H; Yoshida, T; Yoshioka, M | 1 |
| Skotnicki, JS; Steinbaugh, BA | 1 |
| Adam, C; Hare, R; Medeiros, AA; Miller, GH; Papa, E | 1 |
| Elson, S; Southgate, R | 1 |
| Kamimura, T; Kawabata, K; Mine, Y; Miyai, K; Takasugi, H; Takaya, T; Yamanaka, H | 1 |
| Amin, SG; Bose, AK; Kapur, JC; Manhas, MS; Sharma, SD | 1 |
| Chugasova, VA; Gauze, GF; Laiko, AV; Terekhova, LP | 1 |
| Edwards, JR; Park, JT; Wise, EM | 1 |
| Penzotti, SC; Poole, JW | 1 |
| Azuma, T; Fugono, T; Hitaka, T; Masuda, T; Minami, I; Morimoto, S; Nomura, H | 1 |
| Masuda, G; Tomioka, S; Uchida, H | 1 |
| Frère, JM; Ghuysen, JM; Leyh-Bouille, M; Perkins, HR | 1 |
| Spitzy, KH | 1 |
| Hou, JP; Poole, JW | 1 |
| Brumfitt, W; Hamilton-Miller, JM | 1 |
| Stork, G; Szajewski, RP | 1 |
| Bose, AK; Chawla, HP; Chib, JS; Dayal, B; Manhas, MS | 1 |
| Bickel, H; Scartazzini, R | 1 |
| Bickel, H; Peter, H | 1 |
| Duncombe, RE; Kirby, SM; Morris, A; O'Callaghan, CH; Waller, RE | 1 |
| Greenwood, D; O'Grady, F | 1 |
| Morris, A; O'Callaghan, C | 1 |
| Chanter, KV; Harris, AM; Kirby, SM; Marshall, MJ; O'Callaghan, CH; Ross, GW | 1 |
| Abraham, EP; Bradley, CH; Fawcett, P; Kluender, H; Sih, CJ | 1 |
| Currie, SA; Hendlin, D; Hernandez, S; Jackson, M; Mata, JM; Mochales, S; Stapley, EO; Woodruff, HB; Zimmerman, SB | 1 |
| Christensen, BG; Firestone, RA; Maciejewicz, NS; Ratcliffe, RW | 1 |
| Cole, M | 1 |
| Cynamon, MH; Granato, PA | 1 |
| Brown, JE; Collins, CD; Del Bene, VE | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 1 |
| Verbist, L | 2 |
| Slack, MP | 1 |
| Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D | 1 |
| Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
| Neu, HC; Prince, AS | 1 |
| Cullmann, W; Dick, W | 1 |
| Nishikawa, J; Tori, K | 1 |
| Motokawa, K; Murakami, K; Takasuka, M; Yoshida, T | 1 |
| Forbes, M; Kuck, NA; Testa, RT | 1 |
| Eley, A; Greenwood, D | 2 |
| Adamsson, L; Dornbusch, K; Gezelius, L; Hallander, H | 1 |
| Rogers, DT; Russell, AD | 1 |
| Labthavikul, P; Neu, HC | 1 |
| O'Grady, FW | 1 |
| Andrews, JM; Hancox, J; Wise, R | 1 |
| Fu, KP; Neu, HC; Romagnoli, MF | 1 |
| Edwards, DJ; Schentag, JJ | 1 |
| Claes, P; Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D; Vanderhaeghe, H | 1 |
| Aoki, H; Okuhara, M | 1 |
| Bossa, R; Galatulas, I | 1 |
| Ogawara, H | 1 |
| Kagami, I; Nakashima, E; Tsuji, A; Yamana, T | 1 |
| Fass, RJ | 1 |
| Baker, S; Cadge, B; Durham, SR; Gillett, AP; Wise, R | 1 |
| Aldridge, KE | 1 |
| Araki, H; Hayashi, T; Kitayama, R; Minami, S; Ochiai, H; Watanabe, Y | 1 |
| Kato, H; Kato, N; Tanaka, Y; Tanaka-Bandoh, K; Ueno, K; Watanabe, K | 1 |
| Brems, DN; Kaiser, RE; Roychoudhury, S; Yeh, WK | 1 |
| Matsumura, N; Minami, S; Mitsuhashi, S | 1 |
| Cabibbo, E; Corulli, M; Dima, F; Fallacara, C; Longo, M; Peroni, L; Pizzi, R; Pollara, PC; Ravizzola, G; Turano, A | 1 |
| Salmon, SA; Watts, JL | 1 |
| Aucott, J; Bonomo, RA; Salata, RA | 1 |
| Barthélémy, M; Hong, LT; Hornstein, M; Labia, R; Péduzzi, J; Sautjeau-Rostoker, C; Scavizzi, M; Vessières, A | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Jones, RN | 1 |
| Angehrn, P; Gubernator, K; Hubschwerlen, C; Page, MG; Specklin, JL | 1 |
| Greenman, J; Hassan, IJ; Millar, MR; Stark, RM | 1 |
| Crowder, MW; McManus-Munoz, S | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 1 |
| Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
| Bradford, PA; Fingerman, IM; Petersen, PJ; White, DG | 1 |
| Abe, T; Domon, H; Fukuoka, T; Ishii, C; Kakuta, M; Kawada, H; Kitayama, A; Ohya, S; Utsui, Y | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Hanaki, H; Hiramatsu, K; Inaba, Y | 1 |
| Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Nishiyama, T; Saika, T | 1 |
| Bonnet, R; Chanal, C; De Champs, C; Labia, R; Sampaio, JL; Sirot, D; Sirot, J | 1 |
| Nishino, T; Oh, T; Okuda, J; Otsuki, M | 1 |
| Giamarellou, H; Kavouklis, E; Kontoghiorgi, K; Voutsinas, D; Voutsinas, P | 1 |
| Andre, C; Arpin, C; Dubois, V; Frigo, C; Melon, B; Melon, M; Quentin, C | 1 |
| Kaminskaia, NV; Lippard, SJ; Spingler, B | 1 |
| Bülow, L; Danielsson, B; Lawung, R; Prachayasittikul, V | 1 |
| Bellais, S; Decousser, JW; Fortineau, N; Nordmann, P; Poirel, L | 1 |
| Stock, I; Wiedemann, B | 1 |
| Chen, M; Xu, Y; Zhang, S | 1 |
| Brown, RS; Montoya-Pelaez, PJ | 1 |
| Caballero-Lopez, J; Carides, A; Friedland, IR; Ortiz-Ruiz, G; Woods, GL | 1 |
| Friedland, I; Jiang, Q; Legua, P; Lema, J; Moll, J; Woods, G | 1 |
| Cajigas, J; Gesser, RM; Imbeault, D; Jasovich, A; Jiang, Q; Jimenez-Cruz, F; Woods, GL | 1 |
| Beach, ML; Biedenbach, DJ; Jones, RN; Kirby, JT; Pfaller, MA | 1 |
| Burdmann, EA; Gesser, RM; Jiang, Q; Reyna, OG; Tomera, KM; Wimmer, WM; Woods, GL | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Sakata, H | 2 |
| Ichimaru, T | 1 |
| Ethiraj, KS; Hakimelahi, GH; Hwu, JR | 1 |
| Gesser, RM; McCarroll, K; Teppler, H; Woods, GL | 1 |
| Jamieson, CE; Lambert, PA; Simpson, IN | 2 |
| Bonneau, S; Nielsen, J; Noorman, H; Robin, J; Schipper, D | 1 |
| Nielsen, J; Thykaer, J | 1 |
| Brans, A; Duval, V; Franssen, C; Frère, JM; Granier, B; Joris, B; Lepage, S; Swinnen, M | 1 |
| Chamani, J; Chao, I; Hakimelahi, GH; Hakimelahi, S; Khodarahmi, GA; Leong, MK; Li, PC; Ly, TW; Moosavi-Movahedi, AA; Shia, KS; Valiyev, F | 1 |
| Inui, K; Katsura, T; Okamura, M; Saito, H; Terada, T | 1 |
| Brown, RS; Gibson, GT; Montoya-Pelaez, PJ; Neverov, AA | 1 |
| Boosten, WH; Bukhanov, AL; Moody, HM; Svedas, VK; Youshko, MI | 1 |
| Bunse, A; Friedlin, E; Hoff, B; Janus, D; Kück, U; Kürnsteiner, H; Schmitt, EK | 1 |
| Bethel, CR; Bonomo, RA; Helfand, MS; Hujer, AM | 1 |
| Burgess, DS; Hall, RG | 1 |
| Georgopapadakou, N | 1 |
| Arakawa, Y; Doi, Y; Ito, H; Kubota, T; Shibata, N; Wachino, J; Yagi, T; Yamane, K | 1 |
| Bae, IK; Jeong, BC; Jeong, SH; Jung, HI; Kim, SJ; Kwon, SB; Lee, JH; Lee, SH; Song, JS | 1 |
| Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
| Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
| Kaye, KM; Martin, SI | 1 |
| Cui, WL; Li, WL; Wang, LX; Xu, DX | 1 |
| Barends, TR; Dijkstra, BW; Yoshida, H | 1 |
| Bulitta, J; Burkhardt, O; De Roux, A; Kruse, G; Kurowski, M; Lode, H; Nord, CE; Pletz, MW; Rau, M | 1 |
| Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, SH; Oh, MD; Pai, H | 1 |
| Azanza, JR; Campanero, MA; García-Quetglas, E; Sádaba, B | 1 |
| Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J | 1 |
| Al-Shafi, KM; Avison, MB; Bendle, JS; Bennett, PM; James, PA; Macgowan, AP | 1 |
| Bornand, JE; Fonseca, S; Garbino, J; Sax, H; Uçkay, I | 1 |
| Flores, AR; Parsons, LM; Pavelka, MS | 1 |
| Hoff, B; Kück, U; Schmitt, EK | 1 |
| Barber, MS; Giesecke, U; Minas, W; Reichert, A | 1 |
| Fagerquist, CK; Lehotay, SJ; Lightfield, AR | 1 |
| Burgess, DS; Frei, CR | 1 |
| Dittrich, E; Guttmann, C; Meyer, B; Schmaldienst, S; Thalhammer, F | 1 |
| Brøsen, K; Frimodt-Møller, N; Gahrn-Hansen, B; Madsen, H | 1 |
| Ida, T; Ishikawa, M; Kataoka, H; Maeda, K; Osaki, Y; Sanbongi, Y; Suzuki, T | 1 |
| Blanca, M; Mayorga, C; Montañez, MI; Perez-Inestrosa, E; Rodriguez, R; Suau, R; Torres, MJ | 1 |
| Jayarao, BM; Sawant, AA; Sordillo, LM | 1 |
| Chan, KC; Chan, PH; Chung, WH; Leung, YC; Liu, HB; Wong, KY | 1 |
| Bonomo, RA; Paterson, DL | 1 |
| Chen, WH; Hsueh, PR; Luh, KT | 1 |
| Farny, K; Michault, A; Picot, S; Simac, C | 1 |
| Giakkoupi, P; Sestan-Crnek, S; Skrlin, J; Tambic-Andrasevic, A; Tzouvelekis, LS; Vatopoulos, AC; Vourli, S | 1 |
| Chuang, YM; Ho, YC; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
| Dalhoff, A; Echols, R; Janjic, N | 1 |
| Batard, E; Caillon, J; Kergueris, MF; Le Conte, P; Moreau, P; Navas, D; Potel, G | 1 |
| Cantwell, H; O'Keeffe, M | 1 |
| Appelbaum, PC | 1 |
| Livermore, DM | 2 |
| Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL | 1 |
| Beghi, E; Bendotti, C; Mennini, T | 1 |
| Bush, K; Davies, TA; Shang, W | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Neubert, K; Thondorf, I | 1 |
| Fariñas, MC; García-Palomo, D; Horcajada, JP | 1 |
| Page, MG | 1 |
| Satti, F; Shames, R; Smith, MA; Vellozzi, EM | 1 |
| Kohlhammer, Y; Marre, R; Raspe, H; Schäfer, T; Suttorp, N; Welte, T | 1 |
| Friedrich, C | 1 |
| Holzgrabe, U | 1 |
| Sendzik, J; Stahlmann, R | 1 |
| Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV | 1 |
| Appelbaum, PC; Pankuch, GA | 1 |
| Khardori, N | 1 |
| Bronze, MS; Cooper, TW; Gibbs, WJ; Greenfield, RA | 1 |
| Hamzaoui, A | 1 |
| Geddes, AM; Rolinson, GN | 1 |
| Arnoux, B; Blanca, M; Bousquet, PJ; Demoly, P; Fontaine, C; Mayorga, C; Torres, MJ | 1 |
| Li, JT; Markus, P; Matesic, D; Park, M | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Charlier, P; Davies, C; Josephine, HR; Nicholas, RA; Pratt, RF | 1 |
| Agrawal, G; Jalgaonkar, SV | 1 |
| Cisneros-Farrar, F; Parsons, LC | 1 |
| Aguilar, L; Alou, L; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Pichichero, ME | 1 |
| Bush, K; Heep, M; Macielag, MJ; Noel, GJ | 1 |
| Kerp, B; Kress, C; Schneider, E; Seidler, C; Usleber, E | 1 |
| De Zutter, L; Okerman, L; Van Hende, J | 1 |
| Archer, G; Cuirolo, A; Faccone, D; Goldstein, F; Kitzis, MD; Ly, A; Morris, J; Perutka, J; Plata, K; Rosato, AE; Sournia, A | 1 |
| Bröcker, EB; Gross, GE; Seitz, CS; Trautmann, A; Trcka, J | 1 |
| Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH | 1 |
| Kóczián, K; Kökösi, J; Noszál, B; Szakács, Z | 1 |
| Billal, DS; Hotomi, M; Yamanaka, N | 1 |
| Adam, A; Dangor, Y; De Jongh, M; Hoosen, AA | 1 |
| Cohen, R; Grimprel, E | 1 |
| Cornaglia, G; Garau, J; Livermore, DM | 1 |
| Giamarellou, H | 1 |
| Koh, TH; Koh, TY; Wang, G | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Charlier, C; Denooz, R | 1 |
| Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S | 1 |
| Biedenbach, DJ; Fritsche, TR; Jones, RN | 1 |
| Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F | 1 |
| Akita, H; Chiba, N; Hasegawa, K; Iwata, S; Nonoyama, M; Sato, Y; Sunakawa, K; Ubukata, K | 1 |
| Feltrer, R; García-Estrada, C; Godio, RP; Kosalkova, K; Martín, JF; Teijeira, F; Ullán, RV; Vaca, I | 1 |
| Garud, DR; Koketsu, M | 1 |
| Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF | 1 |
| Hu, ZQ; Shimamura, T; Zhao, WH | 1 |
| Lightfield, AR; Mastovska, K | 1 |
| Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F | 1 |
| Cohen, R; Raymond, J | 1 |
| Haldorsen, B; Lundblad, EW; Samuelsen, O; Simonsen, GS; Sundsfjord, A | 1 |
| Hen, K; Imafuku, Y; Yoshida, H | 1 |
| Inui, K; Katsura, T; Okamura, M; Terada, T | 1 |
| Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL | 1 |
| Aggen, JB; Chinn, J; Choi, SK; Christensen, BG; Fatheree, PR; Green, D; Hegde, SS; Judice, JK; Kaniga, K; Krause, KM; Leadbetter, M; Linsell, MS; Long, DD; Marquess, DG; Moran, EJ; Nodwell, MB; Pace, JL; Trapp, SG; Turner, SD | 1 |
| Del Pozo, JL; Patel, R | 1 |
| Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR | 1 |
| Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS | 1 |
| Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Bou, G; Torres, E; Villanueva, R | 1 |
| Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Black, MT; Claudon, M; Girard, AM; Levasseur, P; Miossec, C; Péchereau, MC; Stachyra, T | 1 |
| Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E | 1 |
| Conejo, Mdel C; Hernández, JR; Pascual, A | 1 |
| Alcaide, B; Almendros, P; Pardo, C; Rodríguez-Ranera, C; Rodríguez-Vicente, A | 1 |
| Heim, J; Page, MG | 1 |
| Gentry, LO; Wilkinson, LD | 1 |
| Acred, P; Ryan, DM; Sowa, MA; Watts, CM | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ | 1 |
| Chander, Y; Goyal, SM; Oliveira, S | 1 |
| Cattoir, V; Daurel, C | 1 |
| Lämmerhofer, M; Lindner, W; Schiesel, S | 1 |
| Lee, HJ; Lee, KM; Suh, JT; Yang, HY | 1 |
| Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
| Appelbaum, PC; Kosowska-Shick, K; McGhee, PL | 1 |
| Lode, H | 1 |
| Blanchard, JS; Fan, F; Tremblay, LW | 1 |
| Campi, P; Capretti, S; Ermini, G; Iorno, ML; Macchia, D; Severino, M; Testi, S | 1 |
| Daeseleire, E; De Brabander, HF; Ooghe, S; Reybroeck, W | 1 |
| Caspers, P; Danel, F; Glushkov, AI; Kellenberger, L; Page, MG; Pohlmann, J; Shapiro, S; Vasilevich, NI | 1 |
| De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X | 1 |
| Blanca, M; Torres, MJ | 1 |
| Bjerke, PF; Ferguson, B; Kloos-Olson, KE; Li, JT; Markus, PJ; McClimon, BJ; Odell, L; Park, MA; Swanson, A | 1 |
| Chmielewski, M; Furman, B; Grzeszczyk, B; Kozioł, A; Staszewska-Krajewska, O | 1 |
| Fisher, JF; Llarrull, LI; Mobashery, S; Testero, SA | 1 |
| Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
| Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M | 1 |
| Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA | 1 |
| Cabot, G; Juan, C; Mark, BL; Moyá, B; Oliver, A; Reeve, TM; Vocadlo, DJ; Zamorano, L | 1 |
| Bonomo, RA; Caselli, E; Drawz, SM; Prati, F; Taracila, M | 1 |
| Bovenberg, R; Gidijala, L; Kiela, J; Van Den Berg, M; Vander Keli, I | 1 |
| Bergerová, T; Hrabák, J; Urbásková, P; Zemlicková, H | 1 |
| Cotton, F; De Backer, D; Jacobs, F; Macours, P; Seyler, L; Taccone, FS; Vincent, JL | 1 |
| Kurochkina, VB; Satarova, JE; Sklyarenko, AV; Yarotsky, SV | 1 |
| Bordon, JM; Clark, RB; Karlowsky, JA; Master, RN; Ramirez, J | 1 |
| Gonçalves-Pereira, J; Póvoa, P | 1 |
| Jolly, RS; Moon, LS; Pal, M; Sangar, S | 1 |
| García-Estrada, C; Martín, JF; Ullán, RV | 1 |
| Li, S; May, SL; Nelson, DC; Shen, Y; Zhang, J | 1 |
| Baker, BM; Borbulevych, O; Fishovitz, J; Kumarasiri, M; Lastochkin, E; Llarrull, LI; Mobashery, S | 1 |
| Borde, J; de With, K; Kern, WV; Stocker, H | 1 |
| González, LJ; Vila, AJ | 1 |
| Adnan, S; Kumar, S; Li, J; Lipman, J; Paterson, DL; Roberts, JA; Rudd, M | 1 |
| Culig, J; Erić, M; Leppée, M; Sabo, A | 1 |
| Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P | 1 |
| Davies, TA; Flamm, RK; Lynch, AS | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
| Danel, F; de Castro, L; Gretes, MC; Lovering, AL; Page, MG; Safadi, SS; Strynadka, NC | 1 |
| Trott, D | 1 |
| Bebrone, C; Bennink, S; Bogaerts, P; Delbrück, H; Galleni, M; Glupczynski, Y; Hoffmann, KM; Kupper, MB; Rezende de Castro, R | 1 |
| Aguilar, L; Alou, L; Cafini, F; García, E; Giménez, MJ; Navarro, A; Ramos-Sevillano, E; Rodríguez-Sosa, C; Sevillano, D; Yuste, J | 1 |
| Anaya, J; de Diego, JG; Díez-García, F; Grande, M; Monleón, LM; Rodríguez, FD; Zamora, H | 1 |
| Eller, C; Pfeifer, Y | 1 |
| Ducho, C; Gomez-Castellanos, JR; Hamed, RB; Henry, L; McDonough, MA; Schofield, CJ | 1 |
| Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
| Atanasković-Marković, M; Cirković Veličković, T; Gaeta, F; Gavrović-Jankulović, M; Romano, A; Valluzzi, RL | 1 |
| Caselli, E; Kotsakis, SD; Miriagou, V; Petinaki, E; Prati, F; Tzouvelekis, LS | 1 |
| Fukuya, Y; Ishiguro, N; Kawashima, M; Maeda, A; Suzuki, K; Yamana, Y | 1 |
| Arnold, HM; Hampton, NB; Hoban, A; Hoffmann, J; Hollands, JM; Juang, PH; Kollef, MH; McCormick, S; Micek, ST; Reichley, RM; Skrupky, LP; Smith, JR | 1 |
| Campuzano, S; Conzuelo, F; de las Rivas, B; Esteban-Torres, M; Gamella, M; Muñoz, R; Pingarrón, JM; Reviejo, AJ | 1 |
| Berendsen, BJ; Gerritsen, HW; Lameris, S; Nielen, MW; Stolker, AA; van Sebille, R; Wegh, RS | 1 |
| Berrazeg, M; Drissi, M; Medjahed, L; Rolain, JM | 1 |
| Andersson, I; Blikstad, C; Demetriades, M; Dubus, A; Généreux, C; Hopkinson, RJ; Iqbal, A; Ivison, D; Kershaw, NJ; Lloyd, AJ; McDonough, MA; Roper, DI; Schofield, CJ; Valegård, K | 1 |
| Dewey, CE; Friendship, RM; Park, J; Poljak, Z; Weese, JS | 1 |
| Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN | 1 |
| Chen, Z; Kang, M; Li, D; Tao, C; Wang, T; Xie, Y | 1 |
| Ariza, A; Blanca, M; Corzo, JL; Mayorga, C; Muñoz, C; Requena, G; Torres, MJ; Urda, A; Zambonino, MA | 1 |
| Dien Bard, J; Gold, HS; Hindler, JA; Limbago, B | 1 |
| Goldsmith, T; Griffin, D; Jones, SA; Quintana, J; Rapnicki, P; Salter, RS; Schneider, MJ; Shuck, K; Wells, JE | 1 |
| dos Santos, VM; Ferrer, M; Friedrichs, AK; Heinsen, FA; Knecht, C; Knecht, H; Neulinger, SC; Ott, SJ; Rosenstiel, PC; Schilhabel, A; Schmitz, RA; Schreiber, S; Zimmermann, A | 1 |
| Singh, HL; Singh, RM | 1 |
| Elphick, HE; Jahnke, N | 1 |
| Agersø, Y; Hasman, H; Jensen, JD; Pedersen, K | 1 |
| Fernandez, R; Paz, LI; Rosato, AE; Rosato, RR | 1 |
| Chang, M; Fishovitz, J; Hermoso, JA; Mobashery, S | 1 |
| Charlier, P; Galleni, M; Gutkind, G; Herman, R; Kerff, F; Power, P; Ruggiero, M; Sapunaric, F; Sauvage, E | 1 |
| Afonso, AC; Burrows, LL; Harvey, H; Hogan, AJ; Nguyen, UT; Wright, GD | 1 |
| Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
| Macy, E | 2 |
| Blanchette, LM; Kuti, JL; Nailor, MD; Nicolau, DP | 1 |
| Hong, MK; Jeon, JH; Jo, JY; Kang, LW; Karim, AM; Kim, JH; Ko, KS; Lee, JH; Lee, JJ; Lee, SH; Park, KS | 1 |
| Cao, Y; Ding, Z; Gong, Y; Jiang, H; Liu, X; Song, X; Wang, F; Wang, T; Wang, W; Zhang, N; Zhang, W; Zhang, Z | 1 |
| Abdelhamed, AM; Bajaksouzian, S; Bonomo, RA; Foster, AN; Gatta, JA; Jacobs, MR; Nichols, WW; Papp-Wallace, KM; Testa, R; Winkler, ML | 1 |
| Barber, KE; Raut, A; Rybak, MJ; Smith, JR | 1 |
| Carlson, EE; Kocaoglu, O; Tsui, HC; Winkler, ME | 1 |
| Nord, CE; Panagiotidis, G; Rashid, MU; Rosenborg, S; Söderberg-Löfdal, K; Weintraub, A | 1 |
| Cao, J; Chui, D; Huang, H; Wang, H; Xiao, S | 1 |
| Barlow, M; Meza, JC; Mira, PM; Nandipati, A | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Blaszczyk, AJ; Booker, SJ; Buller, AR; Grove, TL; Lloyd, EP; Marous, DR; Moshos, KA; Townsend, CA | 1 |
| Chambers, L; Knowlton, K; Littier, H; Pruden, A; Ray, P; Strickland, M; Yang, Y; Zhang, T | 1 |
| Kaspar, H; Kehrenberg, C; Klein, G; Kopp, PA; Meemken, D; Prüller, S; Rensch, U | 1 |
| Cairns, KA; Cheng, AC; Ding, A; Dooley, MJ; Evans, JA; Nguyen, T; Trubiano, JA | 1 |
| Hammer, E; Hildebrandt, O; Lindequist, U; Mikolasch, A; Schlüter, R; Witt, S | 1 |
| Callens, B; Catry, B; de Kruif, A; Dewulf, J; Haesebrouck, F; Maes, D; Opsomer, G; Pardon, B; Vanrobaeys, M | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Chambers, HF; Chan, LC; Chatterjee, SS; Chiu, CY; Greninger, AL; Hamilton, SM | 1 |
| Bork, JT; D'Angelo, RG; Heil, EL; Johnson, JK | 1 |
| Damer, KM; Roman, C; Solh, T | 1 |
| Basuino, L; Chambers, HF; Chan, LC; Chatterjee, SS; da Costa, TM; Dos Santos, KR; Gilbert, A; Hamilton, SM | 1 |
| Bolland, MJ; Ferreira, A; Thomas, MG | 1 |
| Basuino, L; Chambers, HF; Choo, EJ; Hamilton, SM; Moise, P | 1 |
| Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
| Cavaco-Silva, P; Matias, CS; Melo-Cristino, J; Mendes, JJ; Mottola, C; Oliveira, M; Tavares, L | 1 |
| Borgia, G; Gentile, I; Maraolo, AE | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Elphick, HE; Scott, A | 1 |
| Amii, R; DeUgarte, DA; Jude, CM; Krishnadasan, A; Moran, GJ; Morim, A; Mower, WR; Pathmarajah, K; Saltzman, DJ; Talan, DA; Wu, JX | 1 |
| Fröding, I; Giske, CG; Vondracek, M | 1 |
| Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF | 1 |
| Breukink, E; Calvez, P; Contreras-Martel, C; Dib, M; Roper, DI; Zapun, A | 1 |
| Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J | 1 |
| Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Seifert, H; Tacconelli, E; Willmann, M | 1 |
| Cantón, R; Chang, KT; Gao, S; Ledesma, KR; Oliver, A; Phe, K; Sánchez-Díaz, AM; Tam, VH; Van Bambeke, F; Zamorano, L; Zhou, J | 1 |
| Adler, NR; Aung, AK; Ergen, EN; Goh, MSY; Phillips, EJ; Trubiano, J | 1 |
| Aedo, S; Alexander, JAN; Basuino, L; Chambers, HF; Chatterjee, SS; Choo, EJ; Chung, M; da Costa, TM; Hamilton, SM; Severin, A; Strynadka, NCJ; Tomasz, A | 1 |
| D'Arcy, S; Doumith, M; Findlay, J; Hopkins, KL; Howe, R; Mather, B; Meunier, D; Mustafa, N; Pike, R; Woodford, N; Wootton, M | 1 |
| Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ | 1 |
| Al-Ahmad, M; Rodriguez-Bouza, T | 1 |
| Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y | 1 |
| Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ | 1 |
| Caputo, I; De Rosa, M; Giordano, D; Marabotti, A; Soriente, A; Verdino, A; Vigliotta, G | 1 |
| Cohen-Wolkowiez, M; Greenberg, RG; Rivera-Chaparro, ND | 1 |
| Arthur, M; Edoo, Z; Hugonnet, JE | 1 |
| Monogue, ML; Nicolau, DP | 1 |
| Ambretti, S; Campoli, C; Gaibani, P; Giannella, M; Landini, MP; Lewis, RE; Re, MC; Viale, P; Volpe, SL | 1 |
| Keller, PM; Müller, DM; Rominski, A; Sander, P; Schulthess, B | 1 |
| Har, D; Solensky, R | 1 |
| Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK | 1 |
| Click, Z; Geswein, L; Varughese, C | 1 |
| Horita, N; Kaneko, T; Namkoong, H; Shibata, Y; Watanabe, H | 2 |
| Das, S; Mandal, RS; Mukherjee, M; Mukherjee, SK | 1 |
| Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Forstner, C; Pletz, MW; Wagenlehner, F; Weis, S | 2 |
| Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y | 1 |
| Cleary, JD; Hall-Lipsy, EA; Jeffres, MN; King, ST | 1 |
| Auguste, PS; Bumann, D; Köhler, T; Luscher, A; Mazza, L; Moynié, L; Naismith, JH; Pletzer, D | 1 |
| Rybak, MJ; Tran, N | 1 |
| Amit, O; Avivi, I; Ben-Ami, R; Halavy, Y; Katchman, E; Kor, S; Paran, Y; Ram, R; Yachini, B | 1 |
| Kamps, JJAG; Lohans, CT; Rabe, P; Schofield, CJ | 1 |
| Boehle, KE; Caraway, J; Carrell, CS; Henry, CS | 1 |
| Bush, K | 1 |
| Floch, P; Gaudru, C; Guet-Revillet, H; Massip, C; Mathieu, C; Miaut, V; Oswald, E; Segonds, C | 1 |
| Benmahmod, AB; Ibrahim, RH; Said, HS | 1 |
| Naber, KG; Wagenlehner, FME | 1 |
| Ammerman, NC; Kaushik, A; Kreiswirth, BN; Lamichhane, G; Lee, J; Martins, O; Nuermberger, EL; Parrish, NM | 1 |
| Fukushima, Y; Hiyama, Y; Masumori, N; Nakajima, C; Sato, T; Shinagawa, M; Suzuki, Y; Takahashi, S; Yokota, SI | 1 |
| Sharma, AK; Vats, P | 1 |
| Berkowitz, DN; Blumenthal, KG; Carballo, VA; Elshaboury, R; Freeley, MM; Gandhi, RG; Gruszecki, A; Hsu, JT; Lambl, BB; Li, Y; Marquis, KA; Schwartz, JM; Shenoy, ES; Wickner, PG; Wolfson, AR | 1 |
| Gould, IM; Hsueh, PR; Jean, SS; Lee, WS | 1 |
| Deng, X; Gao, Y; Niu, X; Sun, L; Wang, G; Wang, X; Yang, Y; Yu, Y | 1 |
| Ghosh, AS; Ghosh, SK; Kumar N, G; Kumar, G; Mallick, S; Pramanick, P | 1 |
| Denzer, C; Essig, A; Pfeifer, Y; Pietsch, M; Posovszky, C; Rabsch, W; Spellerberg, B | 1 |
| Dash, S; Gupta, K | 1 |
| DeShong, P; Ganapati, S; Nanayakkara, IA; Nguyen, HT; Watts, D; White, IM | 1 |
| Higuita-Gutiérrez, LF; Jiménez-Quiceno, JN; Vargas-Alzate, CA | 1 |
| Assier, H; Bérot, V; Chosidow, O; Gaudin, O; Gener, G; Ingen-Housz-Oro, S; Paul, M; Wolkenstein, P | 1 |
| Page, MGP | 1 |
| Cardoso, T; Silva-Nunes, J | 1 |
| Ekundayo, TC; Okoh, AI | 1 |
| Artacho, A; Debrauwer, L; Djukovic, A; Garzón, MJ; González-Barberá, EM; Herrera, B; Kuster, B; López-Hontangas, JL; Peñaranda, I; Rolain, JM; Salavert, M; Sanz, J; Sanz, MA; Ubeda, C; Xavier, JB; Xavier, KB | 1 |
| Kharat, AS; Khobragade, K; Palwe, S | 1 |
| Caputo, I; De Rosa, M; Giordano, D; Marabotti, A; Martucciello, S; Soriente, A; Verdino, A; Vigliotta, G | 1 |
| Boxer, SG; Kozuch, J; Schneider, SH | 1 |
| Bonsall, TJ; Miller, CL; Wilhelm, NB | 1 |
| Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT | 1 |
| Blyth, CC; Bowen, AC; Campbell, AJ; McMullan, BJ; McNeil, JC; Montgomery, CP; Tong, SYC | 1 |
| Dumina, M; Eldarov, M; Valiakhmetov, A; Zhgun, A | 1 |
| Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
| Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
| Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
| Bhalodi, AA; Gamage, D; Humphries, RM; Oppermann, N; Shamsheyeva, A; Sikorski, A | 1 |
| Ibrahim, D; Jabbour, JF; Kanj, SS | 1 |
| Abbaszadeh, F; Baradaran, B; Dehghani, L; Hasani, A; Rezaee, MA; Samadi Kafil, H; Vahhabi, A | 1 |
| Fink, G; Horn, S; Kern, WV | 1 |
| Fisher, JF; Mobashery, S | 1 |
| Bagheri, H; Dao, VT; Montastruc, JL; Nguyen, HA; Nguyen, KD; Vu, DH | 1 |
| Blumenthal, KG; Fu, X; Mancini, CM; Naureckas Li, C; Zhang, Y | 1 |
| Bhowmick, T; Blumenthal, KG; Fu, X; Lee, F; Mancini, CM; Postelnick, M; Schulz, LT; Wimmer, M; Zhang, Y | 1 |
| Blanca-Lopez, N; Fernandez, J; Jimenez-Rodriguez, TW | 1 |
| Cho, HS; D'Souza, R; Kim, H; Lee, H; Nguyen, LP; Pinto, NA; Vu, TN; Yong, D | 1 |
| Holland, P; Jahnke, N | 1 |
| Courter, J; Mortensen, JE; Murphy, ME; Powell, E | 1 |
| Bhagwat, S; Joshi, P; Patel, M; Shrivastava, R | 1 |
| De Puysseleyr, L; Ebo, DG; Elst, J; Faber, MA; Hagendorens, MM; Mertens, CM; Romano, A; Sabato, V; van der Poorten, MM | 1 |
| Eldarov, MA; Zhgun, AA | 1 |
| Chiu, AM; Gaberino, CL; Mahatme, SS | 1 |
| Albur, M; Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR | 1 |
| Ghosh, AS; Jain, D; Mallik, D; Verma, J | 1 |
| Bhathal, S; Goodlet, KJ; Joseph, E; Nailor, MD | 1 |
| Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S | 1 |
| Alcouffe, O; Chagneau, CV; Grare, M; Massip, C; Oswald, E | 1 |
| Batchelder, HR; Lamichhane, G; Nuermberger, EL; Panthi, CM; Rimal, B; Story-Roller, E; Tabor, C; Townsend, CA | 1 |
| Kusaksizoglu, A; Nordmann, P; Ortiz de la Rosa, JM; Poirel, L; Sadek, M; Sakaoglu, Z | 1 |
| Adapa, SR; Atlas, ZD; Chen, Y; Eswara, PJ; Gatdula, JR; Gelis, I; Gongora, MV; Hammond, LR; Jiang, RHY; Keramisanou, D; Lewandowski, EM; Marty, MT; Morgan, RT; Sacco, MD; Sun, X; Townsend, JA; Wang, J; Wang, S; Zhang, X | 1 |
| Oguma, T; Sato, J; Yamawaki, K | 1 |
| Coronel, P; Del Río, I; Domenech, M; Gimeno, M; González-Camacho, F; Lago, D; Llamosí, M; López Ruiz, B; Pérez-García, C; Sempere, J; Yuste, J | 1 |
| Bommarius, AS; Grover, MA; Harris, PR; Rousseau, RW | 1 |
| Agakidis, C; Cassimos, D; Kitsos, N; Mavroudi, A; Xinias, I | 1 |
| Crawford, R; Hobbs, ALV; Hobbs, DA; Perkins, NB | 1 |
| Buranapraditkun, S; Chongpison, Y; Klaewsongkram, J; Mongkolpathumrat, P; Palapinyo, S; Thantiworasit, P | 1 |
| Gehlot, P; P, H | 1 |
| Cabañero-Navalón, MD; Garcia-Bustos, V; Salavert Lletí, M | 1 |
| Azanza Perea, JR; Sádaba Díaz de Rada, B | 1 |
| Gatti, M; Pea, F | 1 |
| Fogarty, K; Green, EA; Ishmael, FT | 1 |
| Broekaert, K; Ooghe, S; Reybroeck, W; Tian, X; Yang, M | 1 |
| Anstey, KM; Blumenthal, KG; Bystritsky, R; Doernberg, SB; Hilts-Horeczko, A; Le, VP; Lee, M; Li, F; Mulliken, JS; Otani, IM; Tang, M; Wang, L; Wattier, RL | 1 |
| Gao, C; Liu, W; Ma, B; Zhu, L | 1 |
87 review(s) available for cephalosporin c and beta-lactams
| Article | Year |
|---|---|
Resistance of Pseudomonas aeruginosa to antimicrobial drugs.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cell Membrane; Cell Membrane Permeability; Cephalosporins; Edetic Acid; Gentamicins; Mutation; Penicillin Resistance; Penicillinase; Penicillins; Polymyxins; Preservatives, Pharmaceutical; Pseudomonas aeruginosa; Tetracyclines | 1975 |
beta-Lactam antibiotics and related substances.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carboxypeptidases; Cephalosporinase; Cephalosporins; Drug Synergism; Humans; Hydrolases; Penicillanic Acid; Penicillin Resistance; Penicillinase; Penicillins; Staphylococcus; Streptomyces; Structure-Activity Relationship | 1977 |
Enzymes involved in beta-lactam antibiotic biosynthesis.
Topics: Amidohydrolases; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Esterases; Fungi; Penicillins; Species Specificity; Transferases | 1977 |
Functional modifications and nuclear analogues of beta-lactam antibiotics--part II.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chemistry, Pharmaceutical; Penicillins; Structure-Activity Relationship | 1977 |
Functional modifications and nuclear analogues of beta-lactam antibiotics--Part I.
Topics: beta-Lactams; Cell Wall; Cephalosporins; Cephamycins; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Structural; Molecular Conformation; Penicillins; Protein Binding; Proteus; Structure-Activity Relationship; Thiazines | 1975 |
Naturally occurring beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Lactams; Penicillins; Thienamycins | 1985 |
-lactam antibiotics: their physicochemical properties and biological activities in relation to structure.
Topics: Amides; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Drug Stability; Drug Synergism; Infrared Rays; Intestinal Absorption; Kinetics; Microbial Sensitivity Tests; Models, Structural; Penicillanic Acid; Penicillins; Solubility; Spectrum Analysis; Structure-Activity Relationship; Ultraviolet Rays | 1971 |
Newer beta-lactam antibiotics.
Topics: Acetamides; Amines; Ampicillin; Azepines; Azides; beta-Lactams; Carbenicillin; Carboxylic Acids; Cephalosporins; Cyclohexanes; In Vitro Techniques; Indenes; Mandelic Acids; Nitriles; Penicillanic Acid; Penicillin G; Penicillins; Pyridines; Sulfonic Acids; Tetrazoles; Thiadiazoles; Thiophenes; Valerates | 1974 |
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
Natural beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Clavulanic Acid; Lactams; Penicillins; Thienamycins | 1980 |
[Beta-lactamines].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Penicillins | 1981 |
Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cell Wall; Cephalosporins; Chemical Phenomena; Chemistry; Penicillin Resistance; Penicillins; Soil Microbiology; Species Specificity; Streptomyces | 1981 |
Oral antibiotics in the nineties: new drugs and new challenges in primary care.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Humans; Macrolides; Physicians, Family; Quinolones | 1997 |
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans | 1998 |
Biological activity of some monocyclic- and bicyclic beta-lactams with specified functional groups.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Bridged Bicyclo Compounds; Cephalosporins; Lactams; Phenols; Structure-Activity Relationship | 2003 |
Metabolic engineering of beta-lactam production.
Topics: Anti-Bacterial Agents; beta-Lactams; Bioreactors; Cephalosporins; Cephamycins; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Fungal; Industrial Microbiology; Mitosporic Fungi; Models, Biological; Penicillins; Protein Engineering; Streptomyces | 2003 |
Beta-lactam antibiotics: newer formulations and newer agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Humans; Lactams; United States | 2004 |
Three-dimensional structures of enzymes useful for beta-lactam antibiotic production.
Topics: Amidohydrolases; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Catalysis; Cephalosporins; Computer Simulation; Drug Design; Models, Molecular; Penicillins; Protein Binding; Protein Conformation; Protein Engineering; Structure-Activity Relationship | 2004 |
Regulation of cephalosporin biosynthesis.
Topics: Acremonium; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Fungal Proteins; Gene Expression Regulation; Genetic Enhancement; Signal Transduction; Species Specificity; Transcription Factors | 2004 |
Industrial enzymatic production of cephalosporin-based beta-lactams.
Topics: Acremonium; Anti-Bacterial Agents; beta-Lactams; Bioreactors; Cell Culture Techniques; Cephalosporins; Drug Industry; Enzymes; Fungal Proteins; Gene Expression Regulation, Fungal; Industrial Microbiology | 2004 |
[Antibiotics and overweight].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Body Weight; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Obesity; Penicillins; Quinolones; Vancomycin | 2005 |
Cephalosporin chemical reactivity and its immunological implications.
Topics: beta-Lactams; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Epitopes; Humans; Immunoglobulin E; Molecular Structure; Risk Factors; Sensitivity and Specificity; Structure-Activity Relationship; Substrate Specificity | 2005 |
Extended-spectrum beta-lactamases: a clinical update.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Microbial Sensitivity Tests; Plasmids | 2005 |
Redefining penems.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Structure; Penicillins | 2006 |
MRSA--the tip of the iceberg.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Gram-Positive Bacteria; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Can beta-lactams be re-engineered to beat MRSA?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Drug Design; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 2006 |
[Treatment of uncomplicated lower urinary tract infections].
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fosfomycin; Humans; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2005 |
Anti-MRSA beta-lactams in development.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Design; Methicillin Resistance; Staphylococcus aureus | 2006 |
[Between chance and deliberate development: the history of beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Germany; History, 20th Century; Humans; Penicillins; United Kingdom | 2006 |
[Structure-activity relationships of penicillin G to tricyclic beta-lactams].
Topics: Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Humans; Penicillin G; Penicillins; Structure-Activity Relationship | 2006 |
[Opposition to Ehrlich's paradigm of selective toxicity. Adverse effects of beta lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Diarrhea; Drug Hypersensitivity; Enterocolitis, Pseudomembranous; Humans; Monobactams; Penicillins | 2006 |
Antibiotics--past, present, and future.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriophages; beta-Lactams; Cephalosporins; Daptomycin; Drug Resistance, Microbial; Drug Therapy; Fluoroquinolones; Glycopeptides; Humans; Macrolides; Oxazolidinones; Streptogramins; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Part II. Introduction to the beta-lactam antibiotics.
Topics: Administration, Oral; Anaphylaxis; Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cross Reactions; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Monobactams; Penicillins; Skin Tests; Time Factors | 2006 |
[Allergy to antibiotics].
Topics: Anaphylaxis; Anti-Bacterial Agents; beta-Lactams; Bronchial Provocation Tests; Cephalosporins; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Humans; Immunoglobulin E; Macrolides; Penicillins; Prognosis; Prospective Studies; Risk Factors; Skin Tests; Urticaria | 2006 |
The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Humans; Hydrolysis; Penicillanic Acid; Penicillins; Thienamycins | 2007 |
Antimicrobials: classifications and uses in critical care.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; beta-Lactams; Cephalosporins; Critical Care; Fluoroquinolones; Humans | 2007 |
Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift.
Topics: Antibody Specificity; beta-Lactams; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Penicillins | 2007 |
Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy.
Topics: Animals; beta-Lactams; Cephalosporins; Drugs, Investigational; Humans; Methicillin Resistance; Staphylococcal Infections; Sulfhydryl Compounds | 2007 |
[Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections].
Topics: Acute Disease; Administration, Oral; Age Factors; Amoxicillin; Anti-Bacterial Agents; Arthritis, Infectious; beta-Lactams; Cephalosporins; Child; Clindamycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Meta-Analysis as Topic; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Defining an extended-spectrum beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Escherichia coli; Gram-Negative Bacteria; Kinetics; Microbial Sensitivity Tests; Mutation | 2008 |
beta-Lactams without a suicide inhibitor.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 2008 |
Health care-associated pneumonia: identification and initial management in the ED.
Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline | 2008 |
[Broad-spectrum beta-lactamases in Gram-negative bacteria].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Penicillins; Plasmids | 2008 |
Ceftobiprole medocaril: a new generation beta-lactam.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Clinical Trials, Phase III as Topic; Humans; Injections, Intravenous; Molecular Structure; Prodrugs | 2008 |
Addressing the challenge of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections | 2009 |
New antimicrobial molecules and new antibiotic strategies.
Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic | 2009 |
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Administration Schedule; Drug Prescriptions; Emergency Service, Hospital; European Union; Fluoroquinolones; Government Agencies; Humans; Macrolides; Product Surveillance, Postmarketing; Respiratory Tract Infections; Safety; United States; United States Food and Drug Administration | 2010 |
The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Clavulanic Acids; Cross Reactions; Drug Hypersensitivity; Humans; Monobactams; Penicillins; Risk Factors; Skin Tests | 2010 |
The future of the β-lactams.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Monobactams | 2010 |
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins | 2010 |
Biosynthesis of active pharmaceuticals: β-lactam biosynthesis in filamentous fungi.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Genetic Engineering; Monobactams; Penicillins; Penicillium chrysogenum; Peptide Synthases; Peroxisomes | 2010 |
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Critical Illness; Humans; Imipenem; Infections; Meropenem; Piperacillin; Thienamycins | 2011 |
Role of peroxisomes in the biosynthesis and secretion of β-lactams and other secondary metabolites.
Topics: Acyltransferases; Amino Acid Sequence; beta-Lactams; Biological Transport; Cephalosporins; Fungi; Hydrogen Peroxide; Molecular Sequence Data; Penicillin-Binding Proteins; Penicillins; Penicillium chrysogenum; Peroxisome-Targeting Signal 1 Receptor; Peroxisomes; Receptors, Cytoplasmic and Nuclear | 2012 |
[Antibiotics: new and old drugs, rational prescription].
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Biological Availability; Cephalosporins; Colistin; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Practice Patterns, Physicians' | 2012 |
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Diffusion; Drainage; Humans; Intraabdominal Infections; Metabolic Clearance Rate; Penicillins | 2012 |
β-lactam resistance in gram-negative pathogens isolated from animals.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Dogs; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Livestock; Pets; Zoonoses | 2013 |
The enzymes of β-lactam biosynthesis.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Humans; Mitosporic Fungi; Molecular Structure; Penicillins | 2013 |
Cephalosporins for patients with penicillin allergy.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Hypersensitivity; Humans; Immunoglobulin E; Penicillins; Skin Tests | 2012 |
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2014 |
Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
Topics: Allosteric Regulation; beta-Lactams; Carbapenems; Cell Wall; Cephalosporins; Cross-Linking Reagents; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Penicillins; Peptide Synthases | 2014 |
Penicillin and beta-lactam allergy: epidemiology and diagnosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Penicillins; Skin Tests | 2014 |
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas.
Topics: Anti-Bacterial Agents; beta-Lactams; Cellulitis; Cephalosporins; Drug Therapy, Combination; Erysipelas; Humans; Lincosamides; Macrolides; Penicillins; Randomized Controlled Trials as Topic | 2016 |
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2016 |
Recent advances in the understanding of severe cutaneous adverse reactions.
Topics: Allopurinol; Anticonvulsants; beta-Lactams; Carbamazepine; Cephalosporins; Dideoxynucleosides; Drug Eruptions; Drug Interactions; Herpesviridae Infections; Humans; Leukocytes, Mononuclear; Pharmacogenetics; Prospective Studies; Skin Tests; T-Lymphocytes; Virus Activation; Virus Latency | 2017 |
Penicillin and Beta-Lactam Hypersensitivity.
Topics: Allergens; Animals; Bacterial Infections; beta-Lactams; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Penicillins | 2017 |
Systematic review of professional liability when prescribing β-lactams for patients with a known penicillin allergy.
Topics: beta-Lactams; Cephalosporins; Drug Hypersensitivity; Humans; Liability, Legal; Malpractice; Penicillins; Physicians; United States | 2018 |
Roles of 2-oxoglutarate oxygenases and isopenicillin N synthase in β-lactam biosynthesis.
Topics: beta-Lactams; Carbapenems; Cephalosporins; Ketoglutaric Acids; Mixed Function Oxygenases; Oxidoreductases; Oxygenases | 2018 |
Past and Present Perspectives on β-Lactamases.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Penicillinase | 2018 |
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans | 2019 |
Preserving the Dwindling β-lactams-Based Empiric Therapy Options for Gram-Negative Infections in Challenging Resistance Scenario: Lessons Learned and Way Forward.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 2020 |
Clinical Management of
Topics: Adolescent; Age Factors; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Cephalosporins; Child; Child, Preschool; Delphi Technique; Drug Administration Schedule; Echocardiography; Endocarditis, Bacterial; Glycopeptides; Humans; Incidence; Infant; Infant, Newborn; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Penicillins; Randomized Controlled Trials as Topic; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; beta-Lactams; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Phage Therapy; Pseudomonas aeruginosa; Pseudomonas Infections | 2020 |
A plethora of carbapenem resistance in
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; beta-Lactams; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymyxin B; Tetracyclines | 2021 |
β-Lactams against the Fortress of the Gram-Positive
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Biocatalysis; Cell Wall; Cephalosporins; Drug Discovery; Enzyme Inhibitors; Humans; Penicillin-Binding Proteins; Penicillins; Protein Binding; Protein Conformation; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Classifying cephalosporins: from generation to cross-reactivity.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Penicillins; Skin Tests | 2021 |
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2021 |
Management of antibiotic allergy in children: a practical approach.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Drug Hypersensitivity; Humans; Penicillins; Quinolones | 2022 |
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Tetracyclines | 2022 |
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting.
Topics: Adult; Albumins; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood Proteins; Catechols; Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Humans; Iron; Meropenem | 2022 |
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2023 |
Penicillin Allergy: Mechanisms, Diagnosis, and Management.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Hypersensitivity; Humans; Hypersensitivity; Penicillins; Skin Tests | 2023 |
The state and consideration for skin test of β-lactam antibiotics in pediatrics.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Drug Hypersensitivity; Humans; Monobactams; Pediatrics; Penicillins; Skin Tests | 2023 |
16 trial(s) available for cephalosporin c and beta-lactams
| Article | Year |
|---|---|
The effect of acetazolamide on the kinetics of four newer beta-lactams in the aqueous humor.
Topics: Acetazolamide; Aged; Aged, 80 and over; Aqueous Humor; Aztreonam; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Endophthalmitis; Female; Humans; Male; Middle Aged | 2001 |
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Tolerance; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2002 |
Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
Topics: Aged; Anesthetics, Local; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Injections, Intramuscular; Lactams; Lidocaine; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious | 2002 |
A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.
Topics: Administration, Oral; Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Prospective Studies; Treatment Outcome; Urinary Tract Infections | 2002 |
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Prospective Studies; Urinary Tract Infections | 2002 |
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2003 |
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
Topics: Adult; beta-Lactams; Ceftriaxone; Cephalosporins; Cross-Over Studies; Double-Blind Method; Ertapenem; Feces; Female; Humans; Intestines; Lactams; Male; Mass Spectrometry; Sex Characteristics | 2004 |
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities | 2006 |
Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy.
Topics: Adolescent; Adult; Aged; beta-Lactams; Cephalosporins; Child; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Male; Middle Aged; Penicillins; Predictive Value of Tests; Sensitivity and Specificity; Skin Tests | 2007 |
Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefpodoxime; Ceftizoxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Immunoglobulin E; Male; Middle Aged; Penicillin V; Single-Blind Method; Skin Tests; Treatment Outcome | 2007 |
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome | 2012 |
Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Hospitals, Urban; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Missouri; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2013 |
Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota.
Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Ceftaroline; Cephalosporins; Feces; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Microbial Sensitivity Tests; Young Adult | 2015 |
Antibiotics-First Versus Surgery for Appendicitis: A US Pilot Randomized Controlled Trial Allowing Outpatient Antibiotic Management.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Cefdinir; Cephalosporins; Child; Cost-Benefit Analysis; Drug Therapy, Combination; Ertapenem; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Outpatients; Pain; Pilot Projects; Quality of Life; Severity of Illness Index; Treatment Outcome; United States; Young Adult | 2017 |
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections | 2017 |
Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Febrile Neutropenia; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2018 |
368 other study(ies) available for cephalosporin c and beta-lactams
| Article | Year |
|---|---|
beta-lactamases in bacteroides.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteriological Techniques; Bacteroides; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Cefamandole; Cefoxitin; Cell Wall; Cephalosporinase; Cephalosporins; Furans; Humans; Isoelectric Focusing; Penicillin G; Penicillin Resistance; Penicillinase; Penicillins; Prevotella melaninogenica; Species Specificity | 1978 |
Antigenic properties of polymers formed by beta-lactam antibiotics.
Topics: Ampicillin; Animals; Antigens; beta-Lactams; Cephalosporins; Epitopes; Guinea Pigs; Haplorhini; Papio; Passive Cutaneous Anaphylaxis; Penicillanic Acid; Penicillin G; Polymers; Rabbits; Skin Tests | 1976 |
[Allergic complications in treatment with beta-lactam antibiotics].
Topics: Adult; Anaphylaxis; Animals; Anti-Bacterial Agents; Antibody Formation; Antigens; beta-Lactams; Cephalosporins; Child; Drug Eruptions; Drug Hypersensitivity; Epitopes; Humans; Immunity, Cellular; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Penicillin G; Penicillins; Skin Tests | 1979 |
[The mechanism of action of 2 major families of antibiotics: beta-lactams and aminoglycosides. Practical consequences].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cell Wall; Cephalosporins; Chemical Phenomena; Chemistry; Humans; Penicillins; RNA, Bacterial | 1979 |
Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Drug Interactions; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 1978 |
6-APA and the development of the beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Chemistry; Drug Stability; History, 20th Century; Penicillanic Acid; Penicillin Resistance; Penicillins | 1979 |
Transition state structures of a dipeptide related to the mode of action of beta-lactam antibiotics.
Topics: beta-Lactams; Cephalosporins; Chemical Phenomena; Chemistry; Dipeptides; Glycine; Molecular Conformation; Penicillins; Structure-Activity Relationship | 1977 |
Clavulanic acid, a novel inhibitor of beta-lactamases.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Drug Synergism; Kinetics; Microbial Sensitivity Tests | 1978 |
Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Carbenicillin; Cephalosporins; Cephalothin; Drug Interactions; Penicillin G; Penicillins | 1979 |
beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli.
Topics: Amidohydrolases; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cefoxitin; Cephalosporinase; Cephalosporins; Chemical Phenomena; Chemistry; Escherichia coli; Furans; Hydrolysis; Penicillin Resistance; Penicillinase | 1978 |
Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.
Topics: Amidohydrolases; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporinase; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Klebsiella pneumoniae; Microbial Sensitivity Tests; Time Factors | 1978 |
Synthetic studies on beta-lactam antibiotics. Part 101. Synthesis of 7beta-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7alpha-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]-methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid disodium salt (6059-S) and its relate
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Methods; Microbial Sensitivity Tests | 1979 |
A new method of estimation of beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Culture Media; Methods; Penicillic Acid; Penicillins | 1979 |
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Microbial Sensitivity Tests | 1979 |
Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source.
Topics: beta-Lactams; Cephalosporins; Lysine; Mutation; Penicillin G; Penicillin Resistance; Penicillins; Pseudomonas; Species Specificity | 1979 |
[Studies on beta-lactam antibiotics for medicinal purpose. X. Stability and degradation pattern of sodium 7-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-car
Topics: Anti-Bacterial Agents; beta-Lactams; Cefoperazone; Cephalosporins; Chemical Phenomena; Chemistry; Drug Stability; Solutions; Water | 1979 |
The stereochemistry of beta-lactam formation in cephalosporin biosynthesis.
Topics: Acremonium; beta-Lactams; Cephalosporins; Cysteine; Molecular Conformation; Stereoisomerism | 1978 |
Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
Topics: Animals; Bacteria; beta-Lactams; Cefazolin; Cefoxitin; Cephalosporinase; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Stability; Enterobacteriaceae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillinase | 1977 |
Recent chemical modification of beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Chemical Phenomena; Chemistry; Methods; Penicillins | 1977 |
Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability.
Topics: Absorption; Anti-Bacterial Agents; beta-Lactams; Calorimetry; Cephalosporins; Crystallization; Drug Stability; Penicillin G; Water; X-Ray Diffraction | 1978 |
The LD-carboxypeptidase activity in Gaffkya homari. The target of the action of certain beta-lactam antibiotics on the formation of wall-bound peptidoglycan.
Topics: Anti-Bacterial Agents; beta-Lactams; Carboxypeptidases; Cell Wall; Cephalosporins; Kinetics; Muramic Acids; Oligopeptides; Penicillin G; Peptidoglycan; Streptococcaceae; Uridine Diphosphate N-Acetylmuramic Acid | 1978 |
beta-lactam antibiotics. Novel synthetic routes to cephem-ring system from beta-lactam thiazolines via hydrazinothioazetidinones.
Topics: Azetidines; beta-Lactams; Cephalosporins; Cyclization; Hydrazones; Thiazoles | 1977 |
[Stability of the amidine analogs of penicillin and deacetoxycephalosporin to the penicillinase of Bacillus licheniformis 749/c].
Topics: Amidines; Bacillus; beta-Lactams; Binding Sites; Cephalosporins; Drug Stability; Hydrolysis; Penicillinase; Penicillins; Structure-Activity Relationship | 1977 |
Theoretical studies on beta-lactam antibiotics. I. Conformational similarity of penicillins and cephalosporins to X-D-alanyl-D-alanine and correlation of their structure with activity.
Topics: Alanine; beta-Lactams; Cephalosporins; Models, Structural; Molecular Conformation; Penicillins; Structure-Activity Relationship; Terminology as Topic | 1977 |
Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
Topics: Aminoglycosides; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbenicillin; Cephalosporins; Culture Media; Drug Synergism; Electric Conductivity; Microbial Sensitivity Tests; Osmolar Concentration; Penicillin G; Penicillins | 1977 |
Thermal decomposition of amorphous beta-lactam antibacterials.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chromatography, Thin Layer; Crystallization; Drug Stability; Hot Temperature; Kinetics; Penicillin G; Thermodynamics; Water | 1977 |
Substrate inhibition of beta-lactamases, a method for predicting enzymatic stability of cephalosporins.
Topics: Amidohydrolases; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporinase; Cephalosporins; Enterobacteriaceae; Hydrolysis; Indicators and Reagents; Staphylococcus aureus; Structure-Activity Relationship | 1976 |
Electronic structures of cephalosporins and penicillins. 4. Modeling acylation by the beta-lactam ring.
Topics: Acylation; beta-Lactams; Cephalosporins; Chemical Phenomena; Chemistry; Models, Chemical; Molecular Conformation; Penicillins; Quantum Theory | 1975 |
Letter: Beta-thionolactam analogs of cephalosporins and penicillins.
Topics: beta-Lactams; Cephalosporins; Chemical Phenomena; Chemistry; Penicillins; Thiones | 1975 |
Letter: Biogenetic-type synthesis of penicillin-cephalosporin antibiotics. II. An oxidative cyclization route to beta-lactam thiazoline derivatives.
Topics: beta-Lactams; Cephalosporins; Cyclization; Oxidation-Reduction; Penicillins; Thiazoles | 1975 |
Relative morphological effects induced by cefoxitin and other beta-lactam antibiotics in vitro.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalosporins; Enterobacteriaceae | 1976 |
Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin.
Topics: Bacterial Proteins; beta-Lactams; Carrier Proteins; Cephalosporinase; Cephalosporins; Enzyme Induction; Escherichia coli; Hexosyltransferases; Hydrolysis; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Structure-Activity Relationship; Thiadiazoles | 1992 |
Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria.
Topics: Animals; Anti-Bacterial Agents; Autoradiography; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Carrier Proteins; Catechols; Cephalosporins; Diffusion Chambers, Culture; Escherichia coli; Hexosyltransferases; Iron; Lactams; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Rats; Siderophores | 1992 |
Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxy-L-ornithine-derived siderophore-beta-lactam conjugates: iron-transport-mediated drug delivery.
Topics: Anti-Bacterial Agents; Azetidines; beta-Lactams; Biological Transport; Cephalosporins; Chemical Phenomena; Chemistry; Drug Carriers; Escherichia coli; Ferrichrome; Iron; Iron Chelating Agents; Lactams; Molecular Structure; Mutation; Shigella flexneri; Siderophores | 1991 |
Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Citrobacter; Enzyme Induction; Gram-Negative Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sepsis | 1987 |
Synthesis of a novel 2 beta-methyl-1-oxacephalosporin, OCP-9-176.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Structure-Activity Relationship | 1988 |
Development of beta-lactam-resistant Enterobacter cloacae in mice.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; beta-Lactams; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Female; Lactams; Male; Mice; Mice, Inbred ICR | 1987 |
Synthesis and biological properties of 7 beta-[(Z)-2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino]-3-cephem- 4-carboxylic acid (7432-S), a new oral cephem antibiotic.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactams; Biological Availability; Ceftibuten; Cephalosporins | 1987 |
Synthesis and antibacterial activity of novel aminothiazolyl beta-lactam derivatives.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Structure-Activity Relationship; Thiazoles | 1986 |
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Topics: Acinetobacter; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Isoelectric Focusing; Lactams; Microbial Sensitivity Tests; Plasmids | 1985 |
Studies on beta-lactam antibiotics. X. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)acetamido] cephalosporin derivatives.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dogs; Magnetic Resonance Spectroscopy; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Studies on beta-lactams. 35. Antibacterial activity of monocyclic beta-lactams.
Topics: Bacillus subtilis; beta-Lactams; Brucella; Cephalosporins; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Penicillins; Spectrophotometry, Infrared; Staphylococcus; Streptococcus; Streptococcus pneumoniae | 1974 |
[Formation of beta-lactam antibiotics by actinomycete cultures].
Topics: Amides; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Hydrolysis; Penicillins; Streptomyces; Streptomyces aureofaciens; Streptomyces griseus | 1972 |
In vivo studies on the uptake and binding of beta-lactam antibiotics in relation to inhibition of wall synthesis and cell death.
Topics: Acyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Binding Sites; Carbon Radioisotopes; Cell Wall; Cephalosporins; Enterococcus faecalis; Glycerol; Microbial Sensitivity Tests; Penicillin G; Penicillins; Peptidoglycan; Staphylococcus; Streptococcus; Tritium | 1974 |
Transport mechanisms of beta-lactam antibiotics across everted rat gut.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport, Active; Cephalexin; Cephaloglycin; Cephaloridine; Cephalosporins; Dicloxacillin; Glucose; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Nafcillin; Penicillin G; Penicillin V; Penicillins; Rats; Surface Tension; Time Factors | 1974 |
Semisynthetic beta-lactam antibiotics. 6. 1 Sulfocephalosporins and their antipseudomonal activities.
Topics: Bacillus subtilis; beta-Lactams; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests; Proteus mirabilis; Proteus vulgaris; Pseudomonas; Pseudomonas aeruginosa; Salmonella; Staphylococcus; Stereoisomerism; Structure-Activity Relationship; Sulfonic Acids | 1974 |
[Effect of beta-lactam antibiotic inactivating substance produced by gram negative rods on the treatment of mixed infection].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Humans; Penicillin Resistance; Penicillins | 1974 |
Interaction between beta-lactam antibiotics and exocellular DD-carboxypeptidase-transpeptidase of Streptomyces R61.
Topics: Acyltransferases; Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Carboxypeptidases; Cephalosporins; Kinetics; Penicillin G; Penicillin V; Peptidoglycan; Protein Binding; Streptomyces | 1974 |
[Appearance of exanthema during hing-dosage therapy with beta-lacta antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cephalosporins; Drug Eruptions; Drug Therapy, Combination; Exanthema; Gentamicins; Humans; Oxacillin; Penicillin G; Penicillins | 1974 |
Carboxy beta-lactams by photochemical ring contraction.
Topics: beta-Lactams; Carboxylic Acids; Cephalosporins; Cyclization; Penicillins; Photochemistry; Stereoisomerism | 1974 |
Studies on beta-lactams. XXXVI. Monocyclic cis beta-lactams via penams and cephams.
Topics: beta-Lactams; Cephalosporins; Cyclization; Hydrogen-Ion Concentration; Penicillins; Spectrum Analysis; Stereoisomerism | 1974 |
[New beta-lactam antibiotics. Derivatives of 3-hydroxy-7-amino-ceph-3-em-4-carboxylic acid].
Topics: Alkylation; Amino Acids; beta-Lactams; Carboxylic Acids; Cephalosporins; Hydroxylation; Methods; Oxidation-Reduction | 1974 |
[New beta-lactam antibiotics. Preparation by decarbonylation of esters of 3-formylcephem compounds].
Topics: beta-Lactams; Cephalosporins; Isomerism; Methods | 1974 |
Correlation between hydrolysis of the -lactam bond of the cephalosporin nucleus and expulsion of the 3-substituent.
Topics: Absorption; Autoanalysis; Azides; beta-Lactams; Cephalosporins; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Enterobacter; Enterobacteriaceae; Escherichia coli; Hydrolysis; Klebsiella; Penicillinase; Pyridines; Spectrophotometry; Ultraviolet Rays | 1972 |
Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.
Topics: Amides; Ampicillin; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactams; Carbenicillin; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Densitometry; Escherichia coli; Microscopy, Electron, Scanning; Osmolar Concentration; Penicillins; Proteus; Proteus mirabilis; Time Factors | 1973 |
Inhibition of beta-lactamases by beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephaloridine; Cephalosporins; Enterobacteriaceae; Nafcillin | 1972 |
Comparison of assay techniques for beta-lactamase activity.
Topics: beta-Lactams; Biological Assay; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cloxacillin; Enterobacteriaceae; Evaluation Studies as Topic; Hydroxylamines; Iodine; Kinetics; Klebsiella; Methicillin; Methods; Oxidation-Reduction; Penicillin G; Penicillinase; Spectrophotometry, Ultraviolet | 1973 |
Synthesis and incorporation of (2S,3S)-(4-13C)valine into beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbon Isotopes; Cephalosporins; Chemical Phenomena; Chemistry; Isotope Labeling; Penicillins; Structure-Activity Relationship; Valine | 1973 |
Electronic structures of cephalosporins and penicillins. 2. Disulfide and beta-lactam chromophores. Structure-activity relationships.
Topics: beta-Lactams; Cephalosporins; Chemical Phenomena; Chemistry; Circular Dichroism; Disulfides; Penicillins; Quantum Theory; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1973 |
Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n.
Topics: Actinomyces; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Microbial Sensitivity Tests; Streptomyces | 1972 |
Total synthesis of beta-lactam antibiotics. IV. Epimerization of 6(7)-aminopenicillins and -cephalosporins from alpha to beta.
Topics: Benzaldehydes; beta-Lactams; Cephalosporins; Chemical Phenomena; Chemistry; Hydrogen-Ion Concentration; Kinetics; Lithium; Methods; Penicillins; Protons | 1974 |
'Beta-lactams' as beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Drug Evaluation, Preclinical; Drug Synergism; Lactams; Penicillins | 1980 |
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin | 1982 |
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1981 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
Topics: Actinomycetaceae; Amdinocillin; beta-Lactams; Carboxypeptidases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Imipenem; Kinetics; Penicillanic Acid; Penicillins; Quinoxalines; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Zinc | 1981 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
[Cephalosporin].
Topics: beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins | 1983 |
[Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Enterobacter; Enterobacteriaceae; Enzyme Induction; Imipenem; Lactams; Penicillin Resistance; Penicillins; Thienamycins | 1984 |
3-Substituent effect and 3-methylene substituent effect on the structure-reactivity relationship of 7 beta-(acylamino)-3-cephem-4-carboxylic acid derivatives studied by carbon-13 and IR spectroscopies.
Topics: beta-Lactams; Cephalosporins; Escherichia coli; Indicators and Reagents; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Structure-Activity Relationship | 1984 |
1-Oxacephalosporins: enhancement of beta-lactam reactivity and antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporinase; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Microbial Sensitivity Tests; Moxalactam | 1981 |
In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Drug Interactions; Male; Mezlocillin; Mice; Penicillins; Piperacillin | 1981 |
A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefsulodin; Cephalosporins; Mezlocillin; Naphthyridines; Nephelometry and Turbidimetry; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Sulbenicillin; Ticarcillin | 1982 |
In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Culture Media; Drug Stability; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enzyme Inhibitors; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1980 |
Antibacterial activity of a monocyclic beta-lactam SQ 26,776.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Pseudomonas aeruginosa | 1981 |
Twenty-one years of beating beta-lactamases.
Topics: Amoxicillin; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Clavulanic Acid; Humans; Penicillin Resistance | 1982 |
Comparative antipseudomonal activity of some newer beta-lactam agents.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cephalosporins; Dose-Response Relationship, Drug; Penicillin Resistance; Pseudomonas aeruginosa | 1982 |
In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefotetan; Cephalosporins; Cephamycins; Microbial Sensitivity Tests | 1982 |
The antibacterial activity of thienamycin against multiresistant bacteria-comparison with beta-lactamase stable compounds.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Thienamycins | 1980 |
In vitro interactions between beta-lactam antibiotics and tobramycin.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cold Temperature; Drug Stability; Kinetics; Penicillinase; Penicillins; Tobramycin | 1981 |
beta-Lactams and beta-lactamases with special reference to cefamandole.
Topics: Bacteria; beta-Lactamases; beta-Lactams; Cefamandole; Cephalosporins; Kinetics; Substrate Specificity | 1980 |
Delta 2- and delta 3-cephalosporins, penicillinate and 6-unsubstituted penems. Intrinsic reactivity and interaction with beta-lactamases and D-alanyl-D-alanine-cleaving serine peptidases.
Topics: Actinomycetaceae; Amides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carboxypeptidases; Cephalosporins; Chemical Phenomena; Chemistry; Hydrolysis; Kinetics; Penicillins; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Structure-Activity Relationship | 1982 |
Intestinal absorption mechanism of amphoteric beta-lactam antibiotics I: Comparative absorption and evidence for saturable transport of amino-beta-lactam antibiotics by in situ rat small intestine.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport, Active; Cephalosporins; Chemical Phenomena; Chemistry, Physical; Gastric Mucosa; Intestinal Absorption; Intestine, Small; Male; Penicillins; Rats; Solubility | 1981 |
New beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Penicillins | 1980 |
In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Topics: Amdinocillin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefoxitin; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Pseudomonas | 1980 |
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Blister; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Floxacillin; Humans; Imidazolidines; Male; Penicillins; Protein Binding | 1980 |
A new potent beta-lactamase inhibitor, BRL 42715, with inherent activity against Bacteroides fragilis group strains.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; In Vitro Techniques; Lactams; Microbial Sensitivity Tests; Species Specificity | 1993 |
In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier Proteins; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Hexosyltransferases; Humans; Lactams; Microbial Sensitivity Tests; Monobactams; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding | 1995 |
[In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; beta-Lactams; Cecum; Cefoperazone; Ceftizoxime; Cephalosporins; Clostridioides difficile; Drug Stability; Drug Therapy, Combination; Imipenem; Lactams; Male; Mice; Mice, Inbred ICR; Sulbactam; Thienamycins | 1996 |
Specific interaction between beta-lactams and soluble penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: development of a chromogenic assay.
Topics: Acylation; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cephalosporins; Chromogenic Compounds; Hexosyltransferases; Kinetics; Lactams; Mass Spectrometry; Methicillin Resistance; Muramoylpentapeptide Carboxypeptidase; Penicillin V; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Staphylococcus aureus; Thiazoles; Urea | 1996 |
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Hydrolysis; Imipenem; Kinetics; Mutation | 1997 |
In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Piperacillin; Teicoplanin; Vancomycin | 1997 |
Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce beta-lactamase.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cattle; Cephalosporins; Cephapirin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Female; Mammary Glands, Animal; Mastitis, Bovine; Novobiocin; Oxacillin; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Enzyme Inhibitors; Hydrolysis; Imipenem; Isoelectric Point; Kinetics; Lactams; Molecular Weight; Oxacillin; Penicillins; Sodium Chloride; Substrate Specificity; Thienamycins | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.
Topics: Acetates; beta-Lactamase Inhibitors; beta-Lactams; Ceftriaxone; Cephalosporins; Citrobacter freundii; Drug Design; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Kinetics; Pseudomonas aeruginosa; Sulfonic Acids | 1998 |
Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefotaxime; Cephalosporins; Colony Count, Microbial; Culture Media; Helicobacter pylori; Microbial Sensitivity Tests; Penicillins | 1998 |
Kinetic mechanism of metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cacodylic Acid; Cephalosporins; Hydrolysis; Indicators and Reagents; Kinetics; Lactams; Software; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Substrate Specificity; Xanthomonas | 1999 |
Multicenter survey of the in vitro activity of four expanded-spectrum beta-lactams against consecutive contemporary clinical isolates.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactams; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests; Monobactams | 1998 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease.
Topics: Animals; beta-Lactamases; beta-Lactams; Cattle; Cattle Diseases; Cephalosporin Resistance; Cephalosporins; Diarrhea; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Virulence | 1999 |
[In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Lactams; Male; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Prodrugs; Streptococcus pneumoniae | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
[Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cephalosporins; Drug Resistance, Microbial; Lactams; Penicillin G; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
[In vitro activity of faropenem against beta-lactamase producing clinical isolates].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Humans; Lactams; Microbial Sensitivity Tests | 2000 |
A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Brazil; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; DNA, Bacterial; Enterobacteriaceae; Gene Transfer Techniques; Humans; Kinetics; Molecular Sequence Data; Sequence Homology, Amino Acid | 2000 |
In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Lactams; Microbial Sensitivity Tests | 2000 |
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Topics: Adult; Amikacin; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping | 2001 |
Intermediate in beta-lactam hydrolysis catalyzed by a dinuclear zinc(II) complex: relevance to the mechanism of metallo-beta-lactamase.
Topics: beta-Lactamases; beta-Lactams; Catalysis; Cephalosporins; Dimethyl Sulfoxide; Hydrogen-Ion Concentration; Hydrolysis; Metalloproteins; Solvents; Substrate Specificity; Water; Zinc | 2001 |
Calorimetric analysis of cephalosporins using an immobilized TEM-1 beta-lactamase on Ni2+ chelating sepharose fast flow.
Topics: Anti-Bacterial Agents; Bacillus cereus; beta-Lactamases; beta-Lactams; Calorimetry; Carbenicillin; Cefoperazone; Cephaloridine; Cephalosporins; Chelating Agents; Chromatography, Affinity; Chromatography, Agarose; Enzymes, Immobilized; Haemophilus ducreyi; Nickel; Penicillinase; Penicillins | 2001 |
Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; Cephalosporins; Chromosomes, Bacterial; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Rahnella; Sequence Homology, Amino Acid | 2001 |
beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium.
Topics: Animals; Aztreonam; beta-Lactams; Carbapenems; Cephalosporins; Culture Media; Dogs; Humans; Microbial Sensitivity Tests; Penicillins; Plesiomonas | 2001 |
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin | 2000 |
Methanolysis of nitrocefin catalyzed by one and two Zn(2+) ions. A simplified model for class B beta-lactamases.
Topics: Algorithms; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Binding Sites; Catalysis; Cations; Cephalosporins; Hydrogen-Ion Concentration; Kinetics; Models, Chemical; Molecular Structure; Substrate Specificity; Temperature; Titrimetry; Zinc | 2002 |
Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fluoroquinolones; Global Health; Humans; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections | 2002 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Study on Streptococcus pneumoniae isolated from infants in widely-separated primary care facilities in Japan].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child Day Care Centers; Child, Preschool; Drug Resistance, Bacterial; Humans; Infant; Japan; Lactams; Otitis Media; Penicillin G; Serotyping; Siblings; Streptococcus pneumoniae | 2001 |
In vitro and in vivo activities of AM-112, a novel oxapenem.
Topics: Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactams; Carrier Proteins; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Hexosyltransferases; Lactams; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 2003 |
Influence of the adipate and dissolved oxygen concentrations on the beta-lactam production during continuous cultivations of a Penicillium chrysogenum strain expressing the expandase gene from Streptomyces clavuligerus.
Topics: Adipates; beta-Lactams; Bioreactors; Cell Culture Techniques; Cephalosporins; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Oxygen; Oxygen Consumption; Penicillium chrysogenum; Protein Engineering; Recombinant Proteins; Solubility; Species Specificity; Streptomyces | 2003 |
The kinetic properties of the carboxy terminal domain of the Bacillus licheniformis 749/I BlaR penicillin-receptor shed a new light on the derepression of beta-lactamase synthesis.
Topics: Acylation; Bacillus; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier Proteins; Cephalosporins; Gene Expression Regulation, Bacterial; Kinetics; Penicillin-Binding Proteins; Penicillins | 2003 |
In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Synergism; Enterococcus faecalis; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactams; Microbial Sensitivity Tests; Staphylococcus aureus | 2003 |
Application of the Barton photochemical reaction in the synthesis of 1-dethia-3-aza-1-carba-2-oxacephem: a novel agent against resistant pathogenic microorganisms.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; beta-Lactams; Cell Division; Cells, Cultured; Cephalosporins; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Humans; Isomerism; Klebsiella pneumoniae; Methicillin; Microbial Sensitivity Tests; Models, Molecular; Pseudomonas aeruginosa; Staphylococcus aureus | 2003 |
Inhibitory effect of zinc on PEPT1-mediated transport of glycylsarcosine and beta-lactam antibiotics in human intestinal cell line Caco-2.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Caco-2 Cells; Carrier Proteins; Cefotiam; Ceftibuten; Cephalosporins; Cephradine; Dipeptides; Humans; In Vitro Techniques; Oocytes; Peptide Transporter 1; Rats; Symporters; Xenopus; Zinc | 2003 |
La3+-catalyzed methanolysis of N-aryl-beta-lactams and nitrocefin.
Topics: beta-Lactams; Catalysis; Cations; Cephalosporins; Hydrogen-Ion Concentration; Kinetics; Lanthanum; Methanol; Potentiometry | 2003 |
Penicillin acylase-catalyzed synthesis of beta-lactam antibiotics in highly condensed aqueous systems: beneficial impact of kinetic substrate supersaturation.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Catalysis; Cephalexin; Cephalosporins; Enzyme Activation; Escherichia coli; Kinetics; Penicillanic Acid; Penicillin Amidase; Solutions; Substrate Specificity; Water | 2004 |
Winged helix transcription factor CPCR1 is involved in regulation of beta-lactam biosynthesis in the fungus Acremonium chrysogenum.
Topics: Acremonium; beta-Galactosidase; beta-Lactams; Binding Sites; Blotting, Southern; Blotting, Western; Cell Membrane; Cephalosporins; Chromatography, High Pressure Liquid; Escherichia coli; Fungal Proteins; Gene Deletion; Gene Expression Regulation; Genes, Reporter; Lac Operon; Models, Genetic; Mutation; Nucleic Acid Hybridization; Penicillins; Peptides; Plasmids; Promoter Regions, Genetic; Protein Binding; Protein Structure, Tertiary; RNA; RNA, Messenger; Time Factors; Transcription Factors; Transcriptional Activation | 2004 |
Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Escherichia coli; Escherichia coli Infections; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2004 |
In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Culture Media, Conditioned; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam; Thienamycins | 2004 |
Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Clinical Trials as Topic; Daptomycin; Drug Design; Drug Evaluation, Preclinical; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Marketing; Mice; Protein Synthesis Inhibitors; Ribosomes; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2004 |
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; Blotting, Southern; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care, Neonatal; Isoelectric Focusing; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2004 |
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
[Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections | 2004 |
Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2004 |
Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftriaxone; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Treatment Outcome | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2004 |
Resistance determinants in strains of Clostridium difficile from two geographically distinct populations.
Topics: Bacterial Proteins; beta-Lactams; Cephalosporins; Clostridioides difficile; Drug Resistance, Bacterial; Genes, Bacterial; Geography; Methyltransferases; Microbial Sensitivity Tests | 2004 |
Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Carbapenems; Cephalosporins; Child, Preschool; Female; Humans; Immunoenzyme Techniques; Legionnaires' Disease; Macrolides; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 2004 |
Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Gene Deletion; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium smegmatis; Mycobacterium tuberculosis; Sequence Alignment | 2005 |
Confirmatory and quantitative analysis of beta-lactam antibiotics in bovine kidney tissue by dispersive solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Calibration; Cattle; Cephalosporins; Chromatography, High Pressure Liquid; Kidney; Methanol; Microbial Sensitivity Tests; Penicillins; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry; Water | 2005 |
Continuous infusion beta-lactams for intensive care unit pulmonary infections.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; United States | 2005 |
Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Cefepime; Ceftazidime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Piperacillin; Renal Dialysis; Treatment Outcome | 2005 |
Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Escherichia coli Proteins; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Recombination, Genetic | 2005 |
A survey on antibiotic usage in dairy herds in Pennsylvania.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cattle Diseases; Cephalosporins; Dairying; Drug Residues; Drug Resistance, Bacterial; Endometritis; Enteritis; Female; Foot Diseases; Mastitis, Bovine; Milk; Pennsylvania; Pneumonia; Surveys and Questionnaires; Tetracyclines | 2005 |
Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Cephalosporins; Fluorescein; Hydrolysis; Kinetics; Molecular Structure; Mutation; Penicillins; Swine | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
[Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004].
Topics: Aza Compounds; beta-Lactams; Cephalosporin Resistance; Cephalosporins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Ketolides; Moxifloxacin; Penicillin Resistance; Quinolines; Retrospective Studies; Reunion; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Transferable DHA-1 cephalosporinase in Escherichia coli.
Topics: Bacterial Proteins; beta-Lactams; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Conjugation, Genetic; Croatia; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2006 |
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries | 2006 |
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactams.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Administration Schedule; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies | 2006 |
Evaluation of the Premi Test and comparison with the One-Plate Test for the detection of antimicrobials in kidney.
Topics: Animals; Anti-Infective Agents; beta-Lactams; Cattle; Cephalosporins; Drug Residues; Drug Stability; Kidney; Reproducibility of Results; Solutions; Sulfonamides; Tetracyclines | 2006 |
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome | 2006 |
New ideas for therapy in ALS: critical considerations.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Humans; Mice; Mice, Transgenic | 2006 |
Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x.
Topics: Amino Acid Motifs; Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Humans; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Streptococcus pneumoniae; United States | 2006 |
Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dipeptides; Models, Molecular; Molecular Conformation; Oligopeptides; Penicillins; Peptide Transporter 1; Protein Binding; Quantitative Structure-Activity Relationship; Symporters | 2006 |
Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Eye; Meropenem; Microbial Sensitivity Tests; Propionibacterium acnes; Rabbits; Thienamycins | 2006 |
Antibiotic treatment of community acquired pneumonia varies widely across Germany.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Germany; Humans; Macrolides; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Practice Patterns, Physicians'; Treatment Outcome | 2007 |
Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae | 2006 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
Reactivity of penicillin-binding proteins with peptidoglycan-mimetic beta-lactams: what's wrong with these enzymes?
Topics: Actinomycetales; beta-Lactams; Binding Sites; Cephalosporins; Escherichia coli; Molecular Mimicry; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Penicillins; Peptidoglycan; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptococcus pneumoniae | 2006 |
Beta-lactam antibiotic susceptibility testing of MRSA?
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; India; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2006 |
Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefuroxime; Cephalosporins; Computer Simulation; Drug Resistance, Bacterial; Haemophilus influenzae; Half-Life; Kinetics; Microbial Sensitivity Tests; Phenotype | 2007 |
Experiences with an identification and quantification program for inhibitor-positive milk samples.
Topics: Ampicillin; Animals; Anti-Infective Agents; beta-Lactams; Cephalosporins; Drug Residues; Food Analysis; Immunoenzyme Techniques; Milk; Penicillin G; Penicillinase; Penicillins; Reproducibility of Results; Sulfonamides | 2007 |
Stability of frozen stock solutions of beta-lactam antibiotics, cephalosporins, tetracyclines and quinolones used in antibiotic residue screening and antibiotic susceptibility testing.
Topics: Agar; Amoxicillin; Bacillus subtilis; beta-Lactams; Cephalosporins; Chemistry Techniques, Analytical; Drug Residues; Hydrogen-Ion Concentration; Methanol; Quinolones; Temperature; Tetracyclines; Time Factors | 2007 |
Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cephalosporins; Chromosomes, Bacterial; DNA-Binding Proteins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Transcription, Genetic | 2007 |
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2007 |
Site-specific protonation microequilibria of penicillin and cephalosporin beta-lactam core molecules.
Topics: beta-Lactams; Cephalosporins; Hydrogen-Ion Concentration; Ions; Magnetic Resonance Spectroscopy; Osmolar Concentration; Penicillanic Acid; Penicillins; Potentiometry; Protons | 2007 |
Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Haemophilus influenzae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2007 |
Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Quinolones; South Africa; Spectinomycin; Tetracycline; Tetracycline Resistance; Urethritis | 2007 |
Living with ESBLs. Introduction.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Microbial Sensitivity Tests; Mutation | 2008 |
High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporin Resistance; Cephalosporins; Ertapenem; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; Singapore | 2008 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Simultaneous determination of five beta-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cefuroxime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Meropenem; Piperacillin; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Thienamycins | 2008 |
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins | 2008 |
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins | 2008 |
[Childhood bacterial meningitis trends in Japan from 2005 to 2006].
Topics: Adolescent; Age Distribution; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Escherichia coli; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Meningitis, Bacterial; Streptococcus pneumoniae; Time Factors | 2008 |
RNA-silencing in Penicillium chrysogenum and Acremonium chrysogenum: validation studies using beta-lactam genes expression.
Topics: Acremonium; beta-Lactams; Cephalosporins; Fungal Proteins; Gene Expression Regulation, Fungal; Genes, Fungal; Genetic Techniques; Mutation; Oxidoreductases; Penicillins; Penicillium chrysogenum; Plasmids; RNA Interference; RNA, Double-Stranded; Transformation, Genetic | 2008 |
Synthesis of 3-selena-1-dethiacephems and selenazepines via iodocyclization.
Topics: Alkynes; Azepines; beta-Lactams; Cephalosporins; Cyclization; Iodine; Organoselenium Compounds | 2008 |
Potency of IMP-10 metallo-beta-lactamase in hydrolysing various antipseudomonal beta-lactams.
Topics: beta-Lactamases; beta-Lactams; Cephalosporins; Hydrolysis; Microbial Sensitivity Tests; Monobactams; Penicillins; Sensitivity and Specificity; Substrate Specificity | 2008 |
Streamlining methodology for the multiresidue analysis of beta-lactam antibiotics in bovine kidney using liquid chromatography-tandem mass spectrometry.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cephalosporins; Chromatography, Liquid; Cloxacillin; Kidney; Penicillins; Reproducibility of Results; Tandem Mass Spectrometry | 2008 |
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia | 2008 |
[Bacteriology of cutaneous infections of the child].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Macrolides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Methyltransferases; Penicillin G; Penicillin Resistance; Penicillins; Risk Factors; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 2008 |
[Induction of PBP2' by antibiotics and disinfectants in MRSE].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Culture Media; Disinfectants; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Staphylococcus epidermidis | 2008 |
Inhibitory effect of zinc on the absorption of beta-lactam antibiotic ceftibuten via the peptide transporters in rats.
Topics: Animals; beta-Lactams; Ceftibuten; Cephalosporins; Intestinal Absorption; Male; Membrane Transport Proteins; Peptide Transporter 1; Rats; Rats, Wistar; Symporters; Zinc | 2008 |
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections | 2009 |
Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dimerization; Drug Design; Drug Discovery; Female; Glycopeptides; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure | 2008 |
[T serotypes distribution and antimicrobial susceptibility of Streptococcus pyogenes in children with pharyngotonsillitis in Asahikawa].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Japan; Macrolides; Pharyngitis; Serotyping; Streptococcus pyogenes; Tonsillitis | 2008 |
Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefuroxime; Cephalosporins; Coculture Techniques; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Selection, Genetic | 2009 |
Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Automation; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Genetic Predisposition to Disease; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary | 2009 |
In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure | 2009 |
Antimicrobial development in the era of emerging resistance.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration | 2009 |
[Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; R Factors; Substrate Specificity | 2010 |
Lewis acid-assisted ene cyclization of 2-azetidinone-tethered enals: synthesis of enantiopure carbacepham derivatives.
Topics: Azetidines; Catalysis; Cephalosporins; Cyclization; Stereoisomerism | 2009 |
New molecules from old classes: revisiting the development of beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria | 2009 |
In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1981 |
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporins; Colony Count, Microbial; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests | 1981 |
In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Aerobic Bacteria; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1981 |
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?].
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial | 2010 |
Characterisation of ceftiofur resistance in swine bacterial pathogens.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Bordetella bronchiseptica; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests; Pasteurella multocida; Polymerase Chain Reaction; Salmonella; Swine; Swine Diseases | 2011 |
Quantitative LC-ESI-MS/MS metabolic profiling method for fatty acids and lipophilic metabolites in fermentation broths from beta-lactam antibiotics production.
Topics: alpha-Tocopherol; Anti-Bacterial Agents; beta-Lactams; Calibration; Cephalosporins; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Fatty Acids; Fermentation; Metabolome; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2010 |
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests | 2009 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Cefotaxime; Ceftaroline; Cephalosporins; Drug Resistance, Microbial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae | 2010 |
Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Cyclotrons; Doripenem; Ertapenem; Fourier Analysis; Hydrogen Bonding; Indicators and Reagents; Kinetics; Mass Spectrometry; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Protein Conformation | 2010 |
Nonirritating concentration for skin testing with cephalosporins.
Topics: beta-Lactams; Cephalosporins; Databases, Factual; Health Planning Guidelines; Humans; Hypersensitivity; Irritants; Maximum Allowable Concentration; Sensitivity and Specificity; Skin Tests | 2010 |
Validation of the betaeta-s.t.a.r. 1 + 1 for rapid screening of residues of beta-lactam antibiotics in milk.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; beta-Lactams; Cephalexin; Cephalosporins; Colony Count, Microbial; Dietary Fats; Drug Residues; European Union; Food Contamination; Food Inspection; Hydrogen-Ion Concentration; Limit of Detection; Milk; Milk Proteins; Penicillin G; Reagent Strips; Reproducibility of Results; Time Factors; Veterinary Drugs | 2010 |
Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA beta-lactams.
Topics: Amides; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Structure-Activity Relationship | 2010 |
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins | 2010 |
Collaboration between allergists and pharmacists increases β-lactam antibiotic prescriptions in patients with a history of penicillin allergy.
Topics: Adult; Aged; Allergy and Immunology; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cooperative Behavior; Drug Hypersensitivity; Drug Prescriptions; Female; Humans; Male; Middle Aged; Penicillins; Pharmacists; Prospective Studies; Skin Tests; Workforce | 2011 |
Ferrier-Petasis rearrangement of 4-(vinyloxy)azetidin-2-ones: an entry to carbapenams and carbacephams.
Topics: Azetidines; Carbapenems; Cephalosporins; Molecular Conformation; Stereoisomerism | 2010 |
Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Biological Transport; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ertapenem; Humans; Imipenem; Kinetics; Lipid Bilayers; Melioidosis; Meropenem; Models, Molecular; Molecular Sequence Data; Norfloxacin; Penicillin G; Phospholipids; Porins; Protein Conformation; Sequence Homology, Amino Acid; Thienamycins | 2011 |
[Evolution of Escherichia coli resistance in community acquired peritonitis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies | 2011 |
AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains.
Topics: Aztreonam; Bacterial Proteins; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins | 2011 |
Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Boronic Acids; Cephalosporinase; Cephalosporins; Cephalothin; Enzyme Inhibitors; Models, Molecular; Molecular Sequence Data; Protein Binding; Pseudomonas aeruginosa; Sequence Alignment; Substrate Specificity | 2011 |
[Interpretation of the susceptibility test results in enterobacteria producing 3rd- and 4th-generation cephalosporin- or carbapenem-hydrolyzing beta-lactamases].
Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests | 2011 |
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Female; Humans; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Prospective Studies; Pseudomonas aeruginosa; Renal Replacement Therapy; Shock, Septic; Thienamycins | 2011 |
Ionization constants and solubility of compounds involved in enzymatic synthesis of aminopenicillins and aminocephalosporins.
Topics: Amino Acids; beta-Lactams; Cephalosporins; Chemistry, Pharmaceutical; Drug Design; Electrolytes; Hydrogen-Ion Concentration; Ions; Models, Chemical; Models, Theoretical; Penicillanic Acid; Penicillins; Solubility; Temperature; Thermodynamics | 2011 |
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2011 |
A catalase-peroxidase for oxidation of β-lactams to their (R)-sulfoxides.
Topics: Absorption; Amino Acids; Bacillus; Bacterial Proteins; beta-Lactams; Biocatalysis; Biotransformation; Cephalosporins; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Hemeproteins; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Molecular Weight; Oxidation-Reduction; Oxidoreductases; Penicillin G; Peroxidases; Reference Standards; Sulfoxides; Temperature | 2012 |
Ratiometric fluorescence detection of pathogenic bacteria resistant to broad-spectrum β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Enterobacter cloacae; Escherichia coli; Fluorescent Dyes; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Sheep; Spectrometry, Fluorescence | 2012 |
An amino acid position at crossroads of evolution of protein function: antibiotic sensor domain of BlaR1 protein from Staphylococcus aureus versus clasS D β-lactamases.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Binding Sites; Catalysis; Cephalosporins; Crystallography, X-Ray; Evolution, Molecular; Metalloendopeptidases; Mutation, Missense; Staphylococcus aureus | 2012 |
Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Chryseobacterium; DNA Primers; DNA, Recombinant; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Immunoprecipitation; Real-Time Polymerase Chain Reaction; RNA, Bacterial | 2012 |
Beta-lactam antibiotics during pregnancy: a cross-sectional comparative study Zagreb-Novi Sad.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Croatia; Cross-Sectional Studies; Drug Utilization; Female; Humans; Infant, Newborn; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome | 2012 |
Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ceftriaxone; Cephalosporins; Genotype; Humans; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Penicillins; Peptide Synthases; Sequence Analysis, DNA; Streptococcus pneumoniae | 2012 |
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies | 2012 |
Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole.
Topics: Anti-Bacterial Agents; beta-Lactams; Calorimetry, Differential Scanning; Catalytic Domain; Cephalosporins; Crystallography, X-Ray; Enzyme Inhibitors; Kinetics; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Conformation; Protein Binding; Protein Conformation; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.
Topics: Acinetobacter baumannii; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Isoenzymes; Kinetics; Models, Molecular; Mutation; Recombinant Proteins; Structure-Activity Relationship | 2012 |
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains.
Topics: Acute-Phase Proteins; Animals; Anti-Bacterial Agents; Antibodies; beta-Lactams; Ceftriaxone; Cephalosporins; Complement Activation; Complement C1q; Complement C3c; Drug Resistance, Microbial; Egtazic Acid; Flow Cytometry; Humans; Immune System; Mice; Phagocytosis; Streptococcus pneumoniae | 2012 |
In vitro evaluation of the antielastase activity of polycyclic β-lactams.
Topics: Animals; beta-Lactams; Cephalosporins; Humans; Leukocyte Elastase; Myeloblastin; Pancreatic Elastase; Protease Inhibitors; Swine | 2012 |
[Current data and trends about the resistance of Gram-negative pathogens to beta-lactams].
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Germany; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Serotyping | 2012 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Diagnosing multiple drug hypersensitivity in children.
Topics: Adolescent; Anti-Bacterial Agents; Anticonvulsants; beta-Lactams; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity; Female; Humans; Ibuprofen; Immunoglobulin E; Male; Patch Tests; Prospective Studies; Skin Tests | 2012 |
Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42.
Topics: Amino Acid Substitution; beta-Lactamases; beta-Lactams; Boronic Acids; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Citrobacter freundii; Escherichia coli; Escherichia coli Proteins; Molecular Dynamics Simulation; Protein Structure, Tertiary | 2013 |
Three cases of perioral dermatitis related to fusobacteria treated with β-lactam antibiotics.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Dermatitis, Perioral; Female; Fusobacterium Infections; Humans; Treatment Outcome | 2014 |
An amperometric affinity penicillin-binding protein magnetosensor for the detection of β-lactam antibiotics in milk.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biosensing Techniques; Cattle; Cephalosporins; Drug Residues; Electrochemical Techniques; Electrodes; Magnetics; Milk; Penicillin-Binding Proteins; Penicillins | 2013 |
Comprehensive analysis of ß-lactam antibiotics including penicillins, cephalosporins, and carbapenems in poultry muscle using liquid chromatography coupled to tandem mass spectrometry.
Topics: Animals; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Chromatography, Liquid; Limit of Detection; Muscle, Skeletal; Penicillins; Poultry; Tandem Mass Spectrometry | 2013 |
Hierarchical clustering as a rapid tool for surveillance of emerging antibiotic-resistance phenotypes in Klebsiella pneumoniae strains.
Topics: Algeria; Algorithms; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cluster Analysis; Computational Biology; Drug Resistance, Bacterial; France; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Prevalence; Software | 2013 |
Structural and mechanistic studies of the orf12 gene product from the clavulanic acid biosynthesis pathway.
Topics: Amino Acid Motifs; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carboxypeptidases; Catalytic Domain; Cephalosporins; Clavulanic Acid; Crystallography, X-Ray; Hydrolysis; Models, Molecular; Penicillins; Protein Conformation; Protein Structure, Tertiary; Serine; Streptomyces | 2013 |
An investigation of resistance to β-lactam antimicrobials among staphylococci isolated from pigs with exudative epidermitis.
Topics: Ampicillin; Animals; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Disk Diffusion Antimicrobial Tests; Epidermitis, Exudative, of Swine; Penicillin G; Staphylococcal Skin Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus hyicus; Swine | 2013 |
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult | 2013 |
[Analysis of the carbapenemase-producing mechanism of Enterobacteriaceae with decreased susceptibility to carbapenems].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Ertapenem; Gene Amplification; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2013 |
Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children.
Topics: Adolescent; Amoxicillin; beta-Lactams; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Immunization; Immunoglobulin E; Infant; Male; Population Groups; Skin Tests | 2014 |
Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefoxitin; Ceftaroline; Cephalosporins; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcal Infections; Staphylococcus; United States; United States Food and Drug Administration | 2014 |
Development and model testing of antemortem screening methodology to predict required drug withholds in heifers.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cephalosporins; Chromatography, High Pressure Liquid; Clonixin; Drug Residues; Female; Kidney; Liver | 2014 |
Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
Topics: Ampicillin; beta-Lactams; Cephalosporins; Clostridioides difficile; Clostridium Infections; Diarrhea; Fluoroquinolones; Gastrointestinal Tract; Humans; Microbiota; RNA, Ribosomal, 16S; Sulbactam | 2014 |
Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; False Negative Reactions; False Positive Reactions; Female; Humans; India; Male; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests | 2014 |
Spread of extended spectrum cephalosporinase-producing Escherichia coli clones and plasmids from parent animals to broilers and to broiler meat in a production without use of cephalosporins.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cephalosporinase; Cephalosporins; Chickens; Denmark; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foodborne Diseases; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poultry; Poultry Diseases | 2014 |
Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftaroline; Cephalosporins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation | 2014 |
Crystal structure of the extended-spectrum β-lactamase PER-2 and insights into the role of specific residues in the interaction with β-lactams and β-lactamase inhibitors.
Topics: Amino Acid Sequence; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Crystallography, X-Ray; Molecular Sequence Data; Protein Binding; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2014 |
Role of PBPD1 in stimulation of Listeria monocytogenes biofilm formation by subminimal inhibitory β-lactam concentrations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Biofilms; Cephalosporins; Disinfectants; Drug Resistance, Bacterial; Gene Knockout Techniques; Listeria monocytogenes; Listeriosis; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Transcription Factors | 2014 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2014 |
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation | 2014 |
Efficacy of cefepime, ertapenem and norfloxacin against leptospirosis and for the clearance of pathogens in a hamster model.
Topics: Animal Structures; Animals; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cricetinae; Disease Models, Animal; Ertapenem; Histocytochemistry; Leptospira interrogans serovar autumnalis; Leptospirosis; Norfloxacin; Survival Analysis; Treatment Outcome | 2014 |
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftaroline; Ceftazidime; Cephalosporins; Escherichia coli; Humans; Microbial Sensitivity Tests | 2015 |
β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Ertapenem; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Doripenem; Electrophoresis, Polyacrylamide Gel; Meropenem; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins | 2015 |
Mass Spectral Profile for Rapid Differentiating Beta-Lactams from Their Ring-Opened Impurities.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry | 2015 |
Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change.
Topics: Adaptation, Physiological; Alleles; Anti-Bacterial Agents; beta-Lactams; Cefprozil; Cephalosporins; Drug Resistance, Microbial; Genes, Bacterial | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Consecutive radical S-adenosylmethionine methylations form the ethyl side chain in thienamycin biosynthesis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catalysis; Cephalosporins; Chromatography, Liquid; Cloning, Molecular; DNA Methylation; Drug Design; Escherichia coli; Fermentation; Methylation; Penicillins; S-Adenosylmethionine; Streptomyces; Tandem Mass Spectrometry; Thienamycins; Vitamin B 12 | 2015 |
Metagenomic Analysis of Antibiotic Resistance Genes in Dairy Cow Feces following Therapeutic Administration of Third Generation Cephalosporin.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cell Cycle; Cell Division; Cephalosporins; Chemotaxis; Drug Resistance, Bacterial; Escherichia coli; Feces; Gene Library; Genes, Bacterial; Manure; Metagenome; Metagenomics; Sequence Analysis, DNA | 2015 |
Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Bordetella bronchiseptica; Cephalosporins; Microbial Sensitivity Tests; Pets; Swine; Thiamphenicol | 2015 |
The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre.
Topics: Administration, Oral; Anti-Infective Agents; Australia; beta-Lactams; Cephalosporins; Drug Hypersensitivity; Drug Labeling; Female; Health Surveys; Humans; Inappropriate Prescribing; Inpatients; Male; Middle Aged; Penicillins; Tertiary Care Centers | 2015 |
Targeted synthesis of novel β-lactam antibiotics by laccase-catalyzed reaction of aromatic substrates selected by pre-testing for their antimicrobial and cytotoxic activity.
Topics: Animals; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Biotransformation; Catalysis; Cephalosporins; Culture Media; Disease Models, Animal; Enterococcus; Female; Gram-Positive Bacteria; Hydroquinones; Industrial Microbiology; Laccase; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Staphylococcus | 2016 |
Effect of Antimicrobial Consumption and Production Type on Antibacterial Resistance in the Bovine Respiratory and Digestive Tract.
Topics: Agriculture; Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cattle Diseases; Cephalosporins; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Respiratory Tract Infections | 2016 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance.
Topics: Bacterial Proteins; beta-Lactams; Ceftaroline; Cephalosporins; Genome, Bacterial; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Mutation; Open Reading Frames; Penicillin-Binding Proteins; Promoter Regions, Genetic; Sequence Analysis, DNA | 2016 |
Who should receive extended infusion beta-lactam therapy?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Patient Selection; Penicillins | 2016 |
PBP 4 Mediates High-Level Resistance to New-Generation Cephalosporins in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcus aureus | 2016 |
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
Topics: Animals; beta-Lactams; Ceftriaxone; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Ertapenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits | 2016 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Biofilms; Ceftaroline; Cephalosporins; Diabetic Foot; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus | 2016 |
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae: inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Reproducibility of Results; Time Factors | 2017 |
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections | 2017 |
Substitutions in PBP2b from β-Lactam-resistant
Topics: Amino Acid Sequence; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Penicillin-Binding Proteins; Protein Denaturation; Recombinant Proteins; Sequence Homology, Amino Acid; Streptococcus pneumoniae | 2017 |
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin | 2017 |
In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Cephalosporins; Colistin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Hospitalization; Humans; Klebsiella; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tetracycline; Tigecycline | 2017 |
Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Humans; Kinetics; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tandem Mass Spectrometry; Thienamycins | 2017 |
High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4).
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Methicillin Resistance; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus | 2017 |
IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Gene Transfer, Horizontal; Humans; Imipenem; Klebsiella; Meropenem; Plasmids; Thienamycins; United Kingdom | 2017 |
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline | 2017 |
Drug allergy evaluation for betalactam hypersensitivity: Cross-reactivity with cephalosporines, carbapenems and negative predictive value.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Child; Cross Reactions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Predictive Value of Tests; Skin Tests | 2018 |
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora.
Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan | 2018 |
Synthesis and biological evaluation of the progenitor of a new class of cephalosporin analogues, with a particular focus on structure-based computational analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cell Survival; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Penicillin-Binding Proteins; Structure-Activity Relationship | 2017 |
Dosing antibiotics in neonates: review of the pharmacokinetic data.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Birth Weight; Body Size; Cephalosporins; Child; Clindamycin; Glycopeptides; Humans; Infant; Infant, Newborn; Medication Reconciliation; Meropenem; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2017 |
Reversible inactivation of a peptidoglycan transpeptidase by a β-lactam antibiotic mediated by β-lactam-ring recyclization in the enzyme active site.
Topics: Acylation; Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Catalytic Domain; Cephalosporins; Cyclization; Enterococcus faecium; Mass Spectrometry; Spectrophotometry | 2017 |
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Disease Models, Animal; Ertapenem; Escherichia coli Infections; Female; Humans; Levofloxacin; Mice, Inbred ICR; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli | 2017 |
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Ertapenem; Gentamicins; Humans; Imipenem; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Tigecycline | 2017 |
Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; Cephalosporins; Drug Stability; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
Comparison of antipseudomonal beta-lactams for febrile neutropenia empiric therapy.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans | 2018 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: authors' response.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans | 2018 |
Effect of non-β-lactams on stable variants of inhibitor-resistant TEM β-lactamase in uropathogenic Escherichia coli: implication for alternative therapy.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Cluster Analysis; Flavanones; Microbial Sensitivity Tests; Molecular Docking Simulation; Phenotype; Polymerase Chain Reaction; Uropathogenic Escherichia coli | 2018 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
[Urosepsis].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections | 2018 |
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis: authors' reply.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans; Neoplasms; Network Meta-Analysis | 2018 |
[Urosepsis].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Sepsis; Urinary Tract Infections | 2018 |
TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Biological Transport; Carrier Proteins; Cefiderocol; Cell Membrane Permeability; Cephalosporins; Membrane Proteins; Monobactams; Pseudomonas aeruginosa; Siderophores; Thiazoles | 2018 |
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Topics: beta-Lactams; Cefazolin; Cefepime; Ceftaroline; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin | 2018 |
Paper-Based Enzyme Competition Assay for Detecting Falsified β-Lactam Antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Counterfeit Drugs; Enzyme Assays; Equipment Design; Microfluidic Analytical Techniques; Paper; Tablets | 2018 |
In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactams; Burkholderia cepacia complex; Burkholderia gladioli; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Tazobactam | 2019 |
Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; DNA Transposable Elements; Egypt; Genes, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing | 2018 |
Novel Antibiotics in the Treatment of Urinary Tract Infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections | 2019 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Boronic Acids; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles.
Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carbapenems; Cephalosporin Resistance; Cephalosporins; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae | 2019 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Outcomes from an inpatient beta-lactam allergy guideline across a large US health system.
Topics: Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Cephalosporins; Decision Support Systems, Clinical; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Inpatients; Male; Middle Aged; Penicillins; Practice Guidelines as Topic; Retrospective Studies; United States; Young Adult | 2019 |
Molecular modeling and QM/MM calculation clarify the catalytic mechanism of β-lactamase N1.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalysis; Catalytic Domain; Cephalosporins; Humans; Hydrolysis; Kinetics; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Dynamics Simulation | 2019 |
Bio-surfactin stabilised silver nanoparticles exert inhibitory effect over New-Delhi metallo-beta-lactamases (NDMs) and the cells harbouring NDMs.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biofilms; Cephalosporins; Escherichia coli; Escherichia coli Infections; Metal Nanoparticles; Microbial Sensitivity Tests; Silver; Surface-Active Agents | 2019 |
Extended-spectrum β-Lactamase Acquisition in Patients Receiving Systemic Cephalosporin Treatment for Salmonella spp. and Shigella spp. Infection.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Humans; Microbial Sensitivity Tests; Plasmids; Salmonella; Shigella | 2020 |
Efficacy of newer β lactams/ β lactamase inhibitors for treatment of multidrug resistant gram negative infections in burn patients.
Topics: Acinetobacter baumannii; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Burns; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Drug Combinations; Drug Development; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa | 2019 |
New Trimodal Phenotypic Reporter of Extended-Spectrum β-Lactamase Activity.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Biosensing Techniques; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxazines; Sulfides | 2019 |
Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cohort Studies; Colombia; Cross Infection; Diagnostic Imaging; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Expenditures; Hospitalization; Hospitals, Urban; Humans; Male; Middle Aged; Tertiary Care Centers; Urinary Tract Infections | 2019 |
Cross-reactivity in beta-lactams after a non-immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions.
Topics: Adult; Aged; beta-Lactams; Cephalosporins; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Risk Factors; Skin Tests | 2020 |
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.
Topics: Bacterial Infections; beta-Lactams; Cefiderocol; Cephalosporins; Drug Design; Drug Development; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Iron; Models, Molecular; Siderophores | 2019 |
Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Cephalosporins; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Retrospective Studies | 2019 |
Antimicrobial resistance in freshwater Plesiomonas shigelloides isolates: Implications for environmental pollution and risk assessment.
Topics: beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Environmental Pollution; Fluoroquinolones; Fresh Water; Humans; Microbial Sensitivity Tests; Plesiomonas; Risk Assessment; South Africa | 2020 |
High Heterogeneity of Multidrug-Resistant
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Culture Media; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Feces; Hospitalization; Humans; Injections, Intravenous; Leukemia; Microbial Sensitivity Tests; Prospective Studies | 2020 |
New compounds for a good old class: Synthesis of two Β-lactam bearing cephalosporins and their evaluation with a multidisciplinary approach.
Topics: Anti-Bacterial Agents; beta-Lactams; Cell Line; Cell Survival; Cephalosporins; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2020 |
Biosynthetic Incorporation of Site-Specific Isotopes in β-Lactam Antibiotics Enables Biophysical Studies.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Binding Sites; Carbon Isotopes; Cefotaxime; Cephalosporins; Drug Discovery; Drug Resistance, Microbial; Penicillin G; Penicillium; Protein Conformation | 2020 |
The Effect of Beta-lactam Allergy Status on the Rate of Surgical Site Infections: A Retrospective Cohort Study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Cefazolin; Cephalosporins; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Risk Factors; Surgical Wound Infection | 2022 |
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome | 2020 |
The critical role of plasma membrane H+-ATPase activity in cephalosporin C biosynthesis of Acremonium chrysogenum.
Topics: Acremonium; Adenosine Triphosphatases; beta-Lactams; Cell Membrane; Cephalosporins; Culture Media; Fermentation; Gene Expression Regulation, Fungal; Proton-Translocating ATPases | 2020 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa Isolates.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
[Antibiotic stewardship - recent developments].
Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Cephalosporins; Fluoroquinolones; Germany; Humans; Neutropenia; Piperacillin, Tazobactam Drug Combination; Urinary Tract Infections | 2020 |
Risk comparison of beta-lactam-induced anaphylaxis: Therapeutic stratification analysis in a Vietnamese pharmacovigilance database.
Topics: Age Factors; Anaphylaxis; Anti-Bacterial Agents; Asian People; beta-Lactams; Carbapenems; Cephalosporins; Drug Therapy, Combination; Humans; Penicillins; Pharmacovigilance; Risk Factors; Sex Factors; Vietnam | 2021 |
Association of beta-lactam allergy documentation and antibiotic use in patients with febrile neutropenia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Hypersensitivity; Febrile Neutropenia; Humans; Meropenem; Penicillins | 2021 |
Association of Penicillin or Cephalosporin Allergy Documentation and Antibiotic Use in Hospitalized Patients with Pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Documentation; Drug Hypersensitivity; Humans; Penicillins; Pneumonia; Retrospective Studies | 2021 |
Role of AmpG in the resistance to β-lactam agents, including cephalosporins and carbapenems: candidate for a novel antimicrobial target.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; CRISPR-Cas Systems; Democratic People's Republic of Korea; DNA Transposable Elements; Gene Expression Regulation, Bacterial; Gene Knockout Techniques; Humans; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutagenesis; Sequence Alignment | 2021 |
Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2021 |
Why Was There Ever a Warning Not to Use Cephalosporins in the Setting of a Penicillin "Allergy"?
Topics: Anaphylaxis; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Penicillins; Skin Tests | 2021 |
Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins | 2021 |
Nonirritant concentrations and performance of ceftaroline skin tests in patients with an immediate β-lactam hypersensitivity.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Skin Tests | 2021 |
Polyamines Upregulate Cephalosporin C Production and Expression of β-Lactam Biosynthetic Genes in High-Yielding
Topics: beta-Lactams; Cephalosporins; Gene Expression Regulation, Fungal; Penicillium chrysogenum; Polyamines; Secondary Metabolism | 2021 |
The effects of beta-lactam allergy relabeling on antibiotic prescribing practices.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Hypersensitivity; Humans; Penicillins | 2022 |
Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Piperacillin; Pseudomonas aeruginosa; Tazobactam | 2022 |
Comparative insight into the roles of the non active-site residues E169 and N173 in imparting the beta-lactamase activity of CTX-M-15.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests | 2022 |
Adherence and outcomes of a surgical prophylaxis guideline promoting cephalosporin use among patients with penicillin allergy.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Hypersensitivity; Humans; Monobactams; Penicillins; Retrospective Studies | 2022 |
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines | 2022 |
Screening for β-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Microbial Sensitivity Tests; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Reproducibility of Results; Streptococcus anginosus | 2022 |
T405, a New Penem, Exhibits
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2022 |
NDM-35-Producing ST167
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2022 |
A unique class of Zn
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cephalosporin Resistance; Cephalosporins; Clostridioides; Clostridioides difficile; Humans; Serine; Zinc | 2022 |
Stereoselective Synthesis of Tricyclic β-Lactam by Sulfoxide-Directed Oxidative Lactonization from an Accessible Cephalosporin Intermediate.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Oxidative Stress; Sulfoxides | 2022 |
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Humans; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Serogroup; Spain; Streptococcus pneumoniae; Vaccines, Conjugate | 2022 |
Selectivity and kinetic modeling of penicillin G acylase variants for the synthesis of cephalexin under a broad range of substrate concentrations.
Topics: beta-Lactams; Cephalexin; Cephalosporins; Kinetics; Penicillin Amidase; Propylene Glycols | 2022 |
Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute; Retrospective Studies | 2022 |
Beta-lactam hypersensitivity diagnosis in ambulatory and hospitalized settings require different approaches.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Penicillins; Skin Tests | 2023 |
Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Data Mining; Molecular Docking Simulation; Monobactams; Penicillins; Tazobactam | 2022 |
Validation of the AnticFast® Beta-Lactams Rapid Test Kit for Detection of Beta-Lactams (Penicillins and Cephalosporins) in Raw Cow's Milk: AOAC Performance Tested MethodSM 032303.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cephalosporins; Drug Residues; Female; Food Contamination; Milk; Monobactams; Penicillins; Sheep | 2023 |
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cephalosporins; Drug Hypersensitivity; Humans; Hypersensitivity; Inpatients; Penicillins; Retrospective Studies | 2023 |